PRN News Briefs

Promotions

• Alex Ebied: Director of Interprofessional Education, High Point University Fred Wilson School of Pharmacy.
• Sarah A. Nisly: Professor, Wingate University School of Pharmacy.
• Jeff Sherer: Clinical Professor, University of Houston College of Pharmacy.

Awards

• Erika Lambert Brechtelsbauer: Patient Safety Award: “Beyond the Call of Duty,” Emory University Hospital Midtown.
• Jay L. Martello: Award of Excellence in Experiential Education, American Association of Colleges of Pharmacy (AACP).
• Charles F. Seifert: 2019 President’s Excellence in Interprofessional Teamwork Award for the Impact Clinic for the development of Lubbock County Indigent Care Clinic, Texas Tech University Health Sciences Center.

Grants

• Jennifer Austin Szwak:University of Chicago Medicine, “Outpatient Principles in Addiction Training and Education (OPIATE) Initiative,” Association of American Medical Colleges Curricular Innovation Award, $2500.

Publications

• Greene R, Rogers R, Adams K, et al. Pharmacokinetics of flucytosine in a critically ill patient on continuous venovenous hemodiafiltration. Am J Health Syst Pharm. [In press]
• Lee C, Austin Szwak J, Bastow S, et al. Impact of a nurse-driven diabetic ketoacidosis insulin infusion calculator on the rate of hypoglycemia. J Patient Saf 2019. [Epub ahead of print]
• Boylan PM, Murzello A, Parmar J, et al. Integration of Latin American complementary and alternative medicine topics into a doctor of pharmacy curriculum and survey of student attitudes and behaviors. J Med Educ Curric Dev 2020;7:1-4.
• Boylan PM, Sedlacek J, Santibañez M, et al. Development and implementation of interprofessional relations between a college of pharmacy and osteopathic residency programs in a community teaching hospital. J Pharm Technol 2020;36:3-9.
• Ebied AM, Nguyen DT, Dang T. Evaluation of occipital nerve blocks for migraines. J Clin Pharmacol 2020;60:378-83.
• Ebied AM, Patel KH, Cooper-DeHoff RM. New drugs approved in 2019. Am J Med 2020 Feb 18. [Epub ahead of print]
• Schwier NC, Cornelio CK, Epperson TM. Managing acute and recurrent idiopathic pericarditis. JAAPA 2020;33:16-22.
• Engle JP, Burke JM, Ashjian EJ, Avery L, Borchert JS, Faro SJ, Harris CS, Herink MC, Jain B, MacLaughlin EJ, Martello JL, et al. ACCP clinical pharmacist competencies: advocating alignment between student, resident, and practitioner competencies. J Am Coll Clin Pharm 2020;3:124-32.
• Moore DC, Elmes J, Shibu P, et al. Mogamulizumab: an anti-CC chemokine receptor 4 antibody for T-cell lymphomas. Ann Pharmacother 2020;54:371-9.
• Moore DC, Ringley JT, Nix D, et al. Impact of obesity on the incidence of bortezomib-induced peripheral neuropathy in patients with newly diagnosed multiple myeloma. Clin Lymphoma Myeloma Leuk 2020;20:168-73.
• Tran T, Arnall J, Moore DC, et al. Vonicog alfa for the management of von Willebrand disease: a comprehensive review and single-center experience. J Thromb Thrombolysis 2020 Jan 4. [Epub ahead of print]
• Nisly SA, Fillius AG, McClain D, et al. Oral antibiotics for the treatment of gram negative blood stream infections: a retrospective comparison of three classes. J Glob Antimicrob Resist 2020;20:74-7.
• Nisly SA, Sebaaly J, Fillius AG, et al. Changes in metacognition through self-evaluation during advanced pharmacy practice experiences. Am J Pharm Educ 2020;84:Article 7489.
• Brammer KE, Brennan L, Phan D, Payne L, Ali A, Davis SM, Nisly SA. Evaluation of a resident-led residency preparation series for fourth year pharmacy students. Innov Pharm 2019;10:Article 12.
• Isaacs AN, Walton AM, Gonzalvo J, Howard ML, Nisly SA. Pharmacy educator evaluation of web-based learning. Clin Teach 2019;16:630-5.
• Nguyen CT, Davis KA, Nisly SA, et al. Treatment of Helicobacter pylori in special patient populations. Pharmacotherapy 2019;39:1012-22.
• Steuber TD, Nisly SA, Gillette C. Grit in pharmacy faculty: a pilot analysis focused on productivity measures. Curr Pharm Teach Learn 2019;11:1029-34.
• Steuber TD, Howard ML, Nisly SA. Direct oral anticoagulants in chronic liver disease. Ann Pharmacother 2019;53:1042-9.
• Summers K, Davis KA, Nisly SA. Bleeding risk of therapeutic unfractionated heparin and low molecular weight heparin in patients with cirrhosis. Clin Drug Investig 2020;40:191-6.
• Horyna TJ, Jimenez R, McMurry L, Buscemi D, Cherry B, Seifert CF. An evaluation of interprofessional patient navigation services in high utilizers at a county tertiary teaching health system. J Healthc Manag 2020;65:62-70.
• Shah S, Peng I, Seifert CF. A model to predict NAPLEX outcomes and identify students needing additional preparation. Curr Pharm Teach Learn 2019;11:810-7.
• Smith SM. Invaded by cancer, and the patient is me. Innov Pharm 2019;10:Article 16.
• Smith SM, Coleman M, Dolder CR. Evaluation of generational influences among 4th year pharmacy students and experiential preceptors. Curr Pharm Teach Learn 2019;11:888-94.
• Marler J, Twilla JD, Finch CK, et al. Severe ceftaroline-induced thrombocytopenia with rapid onset on rechallenge. Ann Pharmacother 2020;54:187-8.
• Wietholter JP, Maynor LM, Clutter JL. A correlation of student personality style and first year academic performance. Am J Pharm Educ 2020 Feb 4. [Epub ahead of print]
• Hill JB, Wietholter JP. Evaluation of risks versus benefits with concomitant use of budesonide nebulizers and systemic corticosteroids in COPD exacerbations. Int J Med Pharm 2019;7:1-5.
• Ilcewicz HN, Coetzee R, Taylor M, Piechowski K, Martello JL, Wietholter JP. Evaluation of pharmacy students’ perceptions of clinical pharmacy in South Africa. J Am Coll Clin Pharm 2020 Feb 13. [Epub ahead of print]

New ACCP Fellows

• Jennifer Twilla

Other Notable Achievements

• Alex Ebied: American College of Clinical Pharmacy (ACCP) Research and Scholarship Academy Certificate.
• Jennifer Twilla:Fellow, Methodist University Hospital

Promotions

• Allison Helmer: Associate Professor, Auburn University Harrison School of Pharmacy.
• Cortney Mospan: Associate Professor, Wingate University School of Pharmacy.
• Mate Soric: Chair, Department of Pharmacy Practice.
• Daniel Touchette: Co-Director, University of Illinois at Chicago Center for Pharmacoepidemiology and Pharmacoeconomic Research.

Awards

• Rhianna Fink: 2019 Next Generation Pharmacist Patient Care Provider Award, Pharmacy Times and Parata Health Systems.
• Diana Isaacs: 2020 Diabetes Care and Education Specialist of the Year, Association of Diabetes Care and Education Specialists (ADCES; formerly AADE).
• Nathan Painter: Excellence in Innovation Award, California Pharmacist Association.

Grants

• Kajua Lor: 2020 Clinical Translational Science Institute Traditional Pilot Award ($50,000).
• Cortney Mospan: CPNP Foundation Defining the Future Grant Mentor ($1500).
• Daniel Touchette: Institute for Clinical and Economic Review ($425,000).

Publications

• Engle JP, Burke JM, Ashjian EJ, Avery L, Borchert JS, Faro SJE, Harris CS, Herink MC, Jain B, MacLaughlin EJ, Martello JL, Moore K, Rogers E, Smith WJ, Stranges PM. ACCP clinical pharmacist competencies: advocating alignment between student, resident, and practitioner competencies. J Am Coll Clin Pharm 2020;1-9.
• Bzowyckyj AS, Begert JE. Diabetes, therapeutic inertia, and patients’ medication experience. Diabetes Spectrum 2020;33:31-7.
• Carlson JJ, Walton SM, Basu A, Chapman RH, Campbell JD, McQueen RB, Pearson SD, Touchette DR, et al. Achieving appropriate model transparency: challenges and potential solutions for making value-based decisions in the United States. Pharmacoeconomics 2019;37:1321-7.
• Lo B, Bicket MC, Carris NW, et al.; National Academies of Sciences, Engineering, and Medicine. Framing Opioid Prescribing Guidelines for Acute Pain: Developing the Evidence. Washington, DC: National Academies Press, 2020.
• Craddock K, Molino S, Stranges PM, Suda KJ, Bleasdale SC, Radosta J, Kannampallil T, Shapiro NL, et al. The impact of educational interventions on antibiotic prescribing for acute upper respiratory tract infections in the ambulatory care setting: a quasi-experimental study. J Am Coll Clin Pharm 2020 Jan 17. [Epub ahead of print]
• Fink RM, Mooney EV, Saseen JJ, et al. A comparison of clinical pharmacist management of type 2 diabetes versus usual care in a federally qualified health center. Pharm Pract 2019;17:1618.
• Mitchell J, Haag J, Klavetter E, et al. Development and implementation of a team-based primary care delivery model: challenges and opportunities. Mayo Clinic Proc 2019;94:1298-303.
• Hager KD, Kading M, O’Donnell C, et al. Bridging community mental health and primary care to improve medication monitoring and outcomes for patients with mental illness taking second generation antipsychotics – HDC/DFMC Bridge Project, phase 1: group concept mapping. Prim Care Companion CNS Disord 2019;2119m02452.
• Hager KD, Schlichte A, Frail CK. This is how I think: evaluation of a preceptor development webinar on incorporating the pharmacists’ patient care process into experiential teaching. Curr Pharm Teach Learn 2019;11:1132-7.
• Sorensen TD, Hager KD, Schlichte A, et al. A dentist, pilot, and pastry chef walk into a bar … why teaching PPCP isn’t enough. Am J Pharm Educ. [In press]
• Hutchison RW. Storage, security, and disposal. J Opioid Manag 2019;15:353-4.
• Ip EJ, Doroudgar S, Lau B, et al. Anabolic steroid users’ misuse of non-traditional prescription drugs. Res Social Adm Pharm 2019;15:949-52.
• Baumgartner L, Ip EJ, Sasaki-Hill D, et al. Implementation of mock acute care advance pharmacy practice experience simulations and an assessment rubric. Am J Pharm Educ 2019;83:1851.
• Cox C, Isaacs D. Why are we stuck? Therapeutic inertia in diabetes education. Diabetes Spectrum 2020;33:16-21.
• Leite KM, Long AM, Ostroff ML, et al. A review of the renoprotective effects of novel antidiabetic agents. J Pharm Pract 2020 Feb 18. [Epub ahead of print]
• Renfro C, Coulter D, Ly L, et al. Exploring pharmacy technician roles in the implementation of an appointment-based medication synchronization program. Pharmacy 2020;8:28.
• Mospan G, Gillette C, Mospan CM. Predictors of performance on the North Carolina multistate pharmacy jurisprudence examination. Curr Pharm Teach Learn 2020;12:35-40.
• Awdishu L, Singh RF, Saunders I, Yam FK, Hirsh JD, Lorentz S, Atayee RS, Ma JD, Tsunoda SM, Namba J, Mnatzaganian CL, Painter NA, et al. Advancing pharmacist collaborative care within academic health systems. Pharmacy 2019;7:142.
• Hsu A, Painter NA. Probable interaction between warfarin and inhaled and oral administration of cannabis. J Pharm Pract July 18, 2019.
• Riccio KK, Rawlins DB, Talbot JN, et al. Demonstration of smartphones as viable tools for adolescent substance use surveillance. Subst Use Misuse 2019 Dec 12. [Epub ahead of print]
• Schumacher C, Van Dril E. Planning and steps to building the ambulatory patient care practice model. In: Kliethermes MA, Brown TR, eds. Building a Successful Ambulatory Care Practice: Advancing Patient Care. Bethesda, MD: American Society of Health-System Pharmacists, 2019:41-79.
• Silva Almodóvar A, Nahata MC. Potentially harmful medication use among medicare patients with heart failure. Am J Cardiovasc Drugs 2020 Feb 21. [Epub ahead of print]
• Bingham J, Silva Almodóvar A, Lee H, et al. The role of the pharmacist in mental health: an investigation of the impact of pharmacist-led interventions on psychotropic medication adherence in patients with diabetes. J Am Pharm Assoc 2020 Jan 24. [Epub ahead of print]
• Soric MM. Study designs: fundamentals, interpretation, and research topics. In: Bernhardt MB, Blackmer A, Capparelli E, et al., eds. Updates in Therapeutics®: Pediatric Pharmacy Preparatory Review and Recertification Course. 2019 ed. Lenexa, KS: American College of Clinical Pharmacy, 2019:865-95.
• Flannery AH, Soric MM, Benavides S, et al. 2019 update to the American College of Clinical Pharmacy Pharmacotherapy Didactic Curriculum Toolkit. J Am Coll Clin Pharm 2019;3:455-64.
• Frost DA, Soric MM, Kaiser R, et al. Efficacy of tramadol for pain management in patients receiving strong cytochrome P450 2D6 inhibitors. Pharmacotherapy 2019;39:724-9.
• Snyder BM, Soric MM. National trends in statin medication prescribing in patients with a history of stroke or transient ischemic attack. J Pharm Pract 2019 Jul 21. [Epub ahead of print]
• Stauffer R, Yancey A. Impact of a pharmacy driven transitions of care medication reconciliation following hospitalization. J Pharm Technol 2020;36:68-71.
• Stranges PM, Jackevicius CA, Anderson SL, Bondi DE, Danelich I, Englin EL, Hansen ML, Nys C, Patel RS, Phan H, Philbrick AM, Rager M, Schumacher C, et al. Role of clinical pharmacists and pharmacy support personnel in transitions of care. J Am Coll Clin Pharm 2020;3:532-45.
• Usmani SA, Reckenberg KA, Johnson O, Stranges PM, et al. Relative risk of adverse events and treatment discontinuations between older and non-older adults treated with antimuscarinics for overactive bladder: a systematic review and meta-analysis. Drugs Aging 2019;36:639-45.
• Agboola F, Atlas SJ, Touchette DR, et al. The effectiveness and value of esketamine for the management of treatment-resistant depression. J Manag Care Spec Pharm 2020;26:16-20.
• Caskey R, Moran K, Touchette D, et al. Effect of comprehensive care coordination on Medicaid expenditures compared with usual care among children and youth with chronic disease: a randomized trial. JAMA Netw Open 2019;2:e1912604.
• Gor D, Gerber BS, Walton SM, Lee TA, Nutescu EA, Touchette DR. Antidiabetic drug use trends in patients with type 2 diabetes mellitus and chronic kidney disease: a cross-sectional analysis of the National Health and Nutrition Examination Survey. J Diabetes 2019 Oct 25. [Epub ahead of print]
• Gor D, Lee TA, Schumock GT, Walton SM, Gerber BS, Nutescu EA, Touchette DR. Adherence and persistence with DPP-4 inhibitors versus pioglitazone in type 2 diabetes patients with chronic kidney disease: a retrospective claims database analysis. J Manag Care Spec Pharm 2020;26:67-75.
• Kim K, Touchette DR, Cavallari LH, et al. Cost-effectiveness of strategies to personalize the selection of P2Y(12) inhibitors in patients with acute coronary syndrome. Cardiovasc Drugs Ther 2019;33:533-46.
• Rodriguez R, Touchette DR. Part II: statistics in practice: statistics overview. J Am Coll Clin Pharm 2019;3:554-9.
• Talon B, Perez A, Yan C, Alobaidi A, Zhang KH, Schultz BG, Suda KJ, Touchette DR. Economic evaluations of clinical pharmacy services in the United States: 2011-2017. J Am Coll Clin Pharm 2019 Dec 10. [Epub ahead of print]
• Van Dril E, Wesling M, Dela Pena L, Schumacher C. Advocating for the pharmacy profession through involvement in a type 1 diabetes day camp as a pharmacy residency learning experience. J Am Pharm Assoc 2019 Dec 31. [Epub ahead of print]
• Cho JC, Wallace TD, Yu FS. Pharmacy faculty and students’ perceptions of standardized patients for objective structured clinical examinations. Curr Pharm Teach Learn 2019;11:1281-6.
• Mastel-Smith B, Garner J, Shoair O, Stocks E, Wallace T. Dementia care boot camp: interprofessional education for healthcare student. J Interprof Care 2019 Dec 13. [Epub ahead of print]
• Gaviola M, Atanda A, Howard M, Yuet WC. A systematic approach to team creation and peer evaluation in a large classroom setting. Curr Pharm Teach Learn 2019;11:1231-8.
• Gibson CM, Yuet WC. Racial and ethnic differences in response to anticoagulation: a review of the literature. J Pharm Pract 2019 Dec 26. [Epub ahead of print]

New ACCP Fellows

• Christie Schumacher: Midwestern University Chicago College of Pharmacy.

Other Notable Achievements

• Mandy Blackford: Became a Board Certified Pharmacotherapy Specialist (BCPS).
• Grace Earl: President-Elect, New Jersey Pharmacists Association. Employed at Fairleigh Dickinson University, Clinical Associate Professor.
• Cortney Mospan: Became a Clinical Pharmacist Practitioner (CPP) in North Carolina.
• Sarah Ochs: First pharmacist in the country to be a Certified Specialist in Obesity and Weight Management (CSOWM).
• Theresa Prosser: Completed certificate in Bioethics.
• Christie Schumacher: Became a Board Certified Cardiology Pharmacist (BCCP).
• Liz Van Dril: Became a Board Certified Ambulatory Care Pharmacist (BCACP).
• Megan Wesling: Became a Board Certified Ambulatory Care Pharmacist (BCACP).

Promotions

• Tien Ng: Full Professor of Clinical Pharmacy and Medicine at the University of Southern California.
• Lydia Tran: Senior Clinical Pharmacy Specialist, Heart and Vascular Services, Yale New Haven Hospital, New Haven, Connecticut.

Awards

• Amy Brewster: Cardiology PRN Seed Grant: “Impact of Pharmacy Transitional Care Activities on Heart Failure Readmission Rates.”
• Leo Buckley: 2019 Foundation Futures Grant Junior Investigator Award.
• Bailey Colvin: ACCP Travel Award.
• Catherine G. Derington: Cardiology PRN outstanding paper: Association of Total Medication Burden with Intensive and Standard Blood Pressure Control and Clinical Outcomes: A Secondary Analysis of SPRINT. Hypertension 2019;74:267-75.
• Michael P. Dorsch: Cardiology PRN Mentoring Award.
• Hannah Hecht: ACCP Travel Awards.
• Andrew Jatis: 2019 Foundation Futures Grant Student Investigator Award.
• Douglas L. Jennings: Cardiology PRN Clinical Practice Award.
• Julie Johnson: Paul F. Parker Medal for Distinguished Service to the Profession of Pharmacy.
• Jason Karnes: ACCP New Investigator Award: “Cardiovascular Pharmacogenomics to Predict Adverse Drug Reactions: Heparin-Induced Thrombocytopenia and Beyond.”
• Kazuhiko Kido: Cardiology PRN Seed Grant: “Evaluating Direct Oral Anticoagulants in Morbidly Obese Patients with Atrial Fibrillation.”
• Robert B. Parker: Cardiology PRN Service Award.
• Sarah A. Spinler: Cardiology PRN Lifetime Achievement Award.
• Jared Van Hooser: Teacher of the Semester, University of Minnesota College of Pharmacy, Fall 2019, Class of 2022.
• Benjamin Van Tassell: Cardiology PRN Distinguished Investigator Award.

Grants

• William L. Baker (Co-Investigator): “Utility of the Intersocietal Accreditation Commission’s Quality Improvement Tool to Reduce Patient Radiation Exposure within U.S. SPECT Laboratories.” Intersocietal Accreditation Commission ($39,000).
• Jim Coons: “Implementation Science, Non-Valvular Atrial Fibrillation Collaborative Project,” Pfizer. Role: Principal Investigator; 2019–2021.
• Katherine E. Di Palo (Primary Investigator): “Real-World Effectiveness of Patiromer as an Acute Hyperkalemia Therapy Within a Tertiary Care Setting. Investigator-Initiated Study.” Awarded $40,700 grant from Vifor Pharma.
• James E. Tisdale (Co-Principal Investigator): “Phenotypic Characterization of Menopausal Palpitations.” Indiana CTSI Collaboration in Translational Research Grant. Funded 2020–2021 ($72,765).

Publications

• Atallah B, Khaddage R, Sadik ZG, et al. Lipid control post coronary artery bypass graft: one year follow-up of a Middle-Eastern cohort. Global Heart 2020;15:12.
• Atallah B, Sadik ZG, Osoble AA, et al. Establishing the first pharmacist‐led heart failure medication optimization clinic in the Middle East Gulf Region. J Am Coll Clin Pharm 2020. [In press]
• Bader F, Mallah S, Atallah B. Choosing the best antithrombotic regimen in patients with ventricular assist devices. Curr Opin Cardiol 2020;35:162-9.
• Baker WL, Beyer-Westendorf J, Bunz TJ, et al. Effectiveness and safety of rivaroxaban and warfarin for prevention of major adverse cardiovascular or limb events in nonvalvular atrial fibrillation patients with type 2 diabetes. Diabetes Obes Metab 2019;21:2107-14.
• Alvarez C, Cronin EC, Baker WL, et al. Heart failure as a substrate and trigger for ventricular tachycardia. J Interv Card Electrophysiol 2019;56:229-47.
• Coleman CI, Kreutz R, Sood N, Bunz T, Eriksson D, Meinecke AK, Baker WL. Rivaroxaban’s impact on renal decline in patients with non-valvular atrial fibrillation: a US MarketScan claims database analysis. Clin Appl Thromb Hemost 2019;25:1-8.
• Coleman CI, Weeda ER, Kharat A, Bookhart B, Baker WL. Impact of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and mortality outcomes in patients with type 2 diabetes and proteinuria. Diabetes Med 2020;37:44-52.
• Martinez BK, Baker WL, Konopka A, Giannelli D, Coleman CI, Kluger J, Cronin EM. Systematic review and meta-analysis of catheter ablation of ventricular tachycardia in ischemic heart disease. Heart Rhythm 2020;17:e206-19.
• Abbate A, Trankle CR, Buckley L, Lipinski MJ, Appleton D, Kadariya D, Canada JM, Carbone S, Roberts CS, Abouzaki N, Melchior R, Christopher S, Turlington J, Mueller G, Garnett J, Thomas C, Markley R, Wohlford G, Puckett L, de Chazal HM, Chiabrando JG, Bressi E, Del Buono MG, Schatz A, Dixon DL, Biondi-Zoccai GG, Kontos MC, Van Tassell BW. Interleukin-1 blockade inhibits the acute inflammatory response in patients with ST-segment-elevation myocardial infarction. J Am Heart Assoc 2020;9:e014941.
• Coons JC, Albert L, Bejjani A, et al. Effectiveness and safety of direct oral anticoagulants versus warfarin in obese patients with acute venous thromboembolism. Pharmacotherapy 2020;40:204-10.
• Coons JC, Pogue K, Kolodziej AR, et al. Pulmonary arterial hypertension: an update. Curr Cardiol Rep 2019;21:141.
• DiDomenico RJ, Dobesh PP, Finks SW. Acute coronary syndromes. In: DiPiro JT, Yee GC, Posey LM, Haines ST, Nolin TD, Ellingrod V, eds. Pharmacotherapy: A Pathophysiologic Approach, 11th ed. New York: McGraw-Hill, 2019:chap 33.
• Patel H, Calip GS, DiDomenico RJ, et al. Prevalence of cardiac risk factors in patients using azithromycin before and after the FDA warning. Pharmacotherapy 2020;40:107-15.
• Di Palo KE. Psychological disorders in heart failure. Heart Fail Clin 2020;16:131-8.
• Di Palo KE, Barone NJ. Hypertension and heart failure: prevention, targets and treatment. Heart Fail Clin 2020;16:99-106.
• Dixon DL, Virani SS. Mortality reduction with PCSK9 inhibition: a case of cautious optimism [invited editorial]. J Clin Lipidol 2019;13:712-3.
• Dixon DL, Wohlford GF, Abbate A. Inflammation and hypertension: causal or not? [invited editorial]. Hypertension 2020;75:297-8.
• Jia X, Ramsey DJ, Rifai MA, Ahmed ST, Akeroyd JM, Dixon DL, et al. Impact of lipid monitoring on treatment intensification of cholesterol lowering therapies (from the Veterans Affairs Healthcare System). Am J Cardiol 2020;125:874-9.
• Finks SW, Rumbak MJ, Self TH. Treating hypertension in chronic obstructive pulmonary disease. N Engl J Med 2020;382:353-63.
• Gibson CM, White A. Patients as teachers of cultural competency in pharmacy education. Innov Pharm 2019;10:Article 7.
• Gibson CM, Yuet WC. Racial and ethnic differences in response to anticoagulation: a review of the literature. J Pharm Pract 2019 Dec 26. [Epub ahead of print]
• Flannery AH, Soric MM, Benavides S, Bobbitt LJ, Chan A, Crannage AJ, Flores EK, Gibson CM, et al. 2019 update to the American College of Clinical Pharmacy Pharmacotherapy Didactic Curriculum Toolkit. J Am Coll Clin Pharm 2019;3:455-64.
• Jackevicius CA, An J, Ko DT, et al. Submissions from the SPRINT Data Analysis Challenge on clinical risk prediction: a cross-sectional evaluation. BMJ Open 2019;9:e025936.
• Jackevicius CA, Krumholz HM, Chong A, et al. Population impact of generic valsartan recall. Circulation 2020;141:411-3.
• Jackevicius CA, Krumholz HM, Ross JS, et al. Clinical outcomes with beta-blocker use in patients with prior history of myocardial infarction. Can J Cardiol 2020 Feb 4. [Epub ahead of print]
• Anderson LJ, Nuckols TK, Coles C, Le MM, Schnipper JL, Shane R, Jackevicius CA, et al.; members of the PHARM-DC Group. A systematic overview of systematic reviews evaluating medication adherence interventions. Am J Health Syst Pharm 2020;77:138-47
• Aranda J, Davies M, Jackevicius CA. Student pharmacists’ performance and perceptions on an evidence-based medicine objective structured clinical examination. Curr Pharm Teach Learn 2019;11:302-8.
• Atzema CL, Jackevicius CA, Chong A, et al. Prescribing of oral anticoagulants and subsequent long-term use by older adults with atrial fibrillation. CMAJ 2019;191:E1345-54.
• Atzema CL, Yu B, Schull MJ, Jackevicius CA, et al. Association of l follow-up care with long-term death and subsequent hospitalization in patients with atrial fibrillation who receive emergency care in the province of Ontario. Circ Arrhythm Electrophysiol 2019;12:e006498.
• Han J, Chung F, Nguyen QL, Mody FV, Jackevicius CA. Evaluation of patients with heart failure to determine eligibility for treatment with sacubitril/valsartan: insights from the Veterans Administration Healthcare System. Pharmacotherapy 2019;39:1053-9.
• Ko D, Azizi P, Koh M, Chong A, Austin P, Stukel T, Jackevicius CA. Comparative effectiveness of ACE inhibitors and angiotensin receptor blockers in patients with prior myocardial infarction. Open Heart 2019;4:e001010.
• Shurrab M, Quinn KL, Kitchlu A, Jackevicius CA, et al. Long-term vitamin K antagonists and cancer risk: a systematic review and meta-analysis. Am J Clin Oncol 2019;42:717-24.
• Sparrow R, Khan A, Ferreira-Legere L, Ko D, Jackevicius CA, et al. Effectiveness of interventions aimed at increasing statin prescribing in primary cardiovascular disease prevention: a systematic review of randomized controlled trials. JAMA Cardiol 2019;4:1160-9.
• Board C,Kelly MS, Shapiro MD, Dixon DL. PCSK9 inhibitors in secondary prevention – an opportunity for personalized therapy. J Cardiovasc Pharmacol 2020 Feb 14. [Epub ahead of print]
• Dong OM, Wheeler SB, Cruden G, Lee CR, et al. Cost-effectiveness of multi-gene pharmacogenetic testing in patients with acute coronary syndrome after percutaneous coronary intervention. Value Health 2020;23:61-73.
• Limdi NA, Cavallari LH, Lee CR, et al. Cost-effectiveness of CYP2C19-guided antiplatelet therapy in patients with acute coronary syndrome and percutaneous coronary intervention informed by real world data. Pharmacogenom J 2020 Feb 11. [Epub ahead of print]
• Mattern H, Reichert J, McConnell KJ. The effect of intravenous acetaminophen on patient outcomes within a large integrated delivery system. Pharmacotherapy 2020 Jan 28. [Epub ahead of print]
• Yin E, McConnell KJ. Request for an Andexxa value analysis. Ann Pharmacother 2020 Jan 23. [Epub ahead of print]
• Schumacher C, Van Dril E. Clinical pharmacist’s role in heart failure management and the expansion of clinical pharmacist services in health care reform. In: Castelli G, ed. ACCP Ambulatory Care Pharmacist’s Survival Guide, 4th ed. Lenexa, KS: American College of Clinical Pharmacy, 2019:125-37.
• Schumacher C, Van Dril E. Planning and steps to building the ambulatory patient care practice model. In: Kliethermes MA, Brown TR, eds. Building a Successful Ambulatory Care Practice: Advancing Patient Care. Bethesda, MD: American Society of Health-System Pharmacists, 2019:41-79.
• Szymanski TW, Weeks PA, Lee Y, et al. Anticoagulation of Impella with a bivalirudin purge solution. ASAIO J 2020 Feb 4. [Epub ahead of print]
• Gorenek B, Fisher JD, Kudaiberdieva G, Baranchuk A, Burri H, Campbell KB, Chung MK, Enriquez A, Heidbuchel H, Kutyifa V, Krishnan K, Leclercq C, Ozcan EE, Patton KK, Shen W, Tisdale JE, et al. Premature ventricular complexes: diagnostic and therapeutic considerations in clinical practice. A state-of-the-art review by the American College of Cardiology Electrophysiology Council. J Interv Card Electrophysiol 2020;57:5-26.
• Muensterman ET, Jaynes HA, Sowinski KM, Overholser BR, Shen C, Kovacs RJ, Tisdale JE. Effect of transdermal testosterone and oral progesterone on drug-induced QT interval lengthening in older men: a randomized, double-blind placebo-controlled crossover-design study. Circulation 2019;140:1127-9.
• Van Hooser JC, Rouse KL, Meyer ML, et al. Knowledge of heart attack and stroke symptoms among US Native American adults: a cross-sectional population-based study analyzing a multi-year BRFSS database. BMC Public Health 2020;20:40.
• Del Buono MG, Bonaventura A, Vecchié A, Wohlford GF, Dixon DL, Van Tassel BW, et al. Sacubitril-valsartan for the treatment of heart failure: time for a paragon? J Cardiovasc Pharmacol 2020;75:105-7.

New ACCP Fellows

• Douglas C. Anderson Jr
• Craig Beavers
• Brent N. Reed
• Christie Schumacher
• Lisa Hall Zimmerman

Other Notable Achievements

• Jim Coons: Designated as a Fellow of the American College of Cardiology.
• Robert J. DiDomenico: Appointed to Board of Pharmacy Specialties Research Committee.
• Katherine E. Di Palo:
  Designated as a Fellow of the American Heart Association and the Heart Failure Society of America.
  Academic appointment – Assistant Professor of Clinical Medicine, Albert Einstein College of Medicine.
  Chair – Council on Clinical Cardiology Clinical Pharmacology Committee, American Heart Association.
• Dave Dixon:
  Appointed Section Editor, Journal of Cardiovascular Pharmacology.
  Appointed Associate Editor, Journal of the American Pharmacists Association.
• Cait Gibson: Appointed to BPS Cardiology Council for 2020–2022.
• Vicki Groo: Elected to ACC CV Team State Liaison for Illinois.
• Tien Ng: Selected to receive the University of Southern California 2020 Associates Award for Excellence in Teaching (only two awarded annually university-wide).
• James E. Tisdale:
  Appointed Consulting Editor (Cardiovascular), Pharmacological Research.
  Reappointed to 3-year term, Electrophysiology Section Leadership Council, American College of Cardiology.
• Barbara Wiggins:
  Editorial Board – American Journal of Cardiovascular Drugs – 2020.
  ACC Cardiovascular Management Section Leadership Council – 2020.
• Lydia Tran:
  Senior Clinical Pharmacy Specialist, Heart and Vascular Services, Yale New Haven Hospital, New Haven, Connecticut.
  Second Vice President, Executive Board Member of the Connecticut Pharmacists Association.

Board Certified Cardiology Pharmacists

• Vicki Groo
• Christie Schumacher
• Thomas Szymanski

Presentations

• Magee C, Spiegel M, Wiggins BS, Lim M. Clopidogrel-induced thrombotic thrombocytopenic purpura with successful transition to ticagrelor. Society of Critical Care Medicine Critical Care Congress; February 16-19, 2020; Orlando, FL.
• Weithorn E, Wiggins BS, Magee C. Evaluation of direct oral anticoagulants (DOACs) in patients greater than or equal to 120 kg. Presented at: American College of Cardiology Annual Meeting; 2020; Chicago, IL.

Awards

• James Cloyd: 2020 recipient of the American Pharmacists Association (APhA) Tyler Prize for simulation of research.

Publications

• Kapur J, Elm J, Chamberlain J, Barsan W, Cloyd J, et al. Randomized trial of three anticonvulsant medications for status epilepticus. N Engl J Med 2019;381:2103-13.
• Nguyen VH, Dergalust S. Epilepsy. In: Munyer T, ed. Pharmacotherapy First, 1st ed. Washington, DC: APhA, 2019.
• Delgado-Escueta AV, Serratosa JM, Bailey JN, Nguyen VH. Genetic tests in epilepsy. In: Bureau M, Genton P, Dravet C, et al., eds. Epileptic Syndromes in Infancy, Childhood, and Adolescence, 6th ed. New York, 2019.
• Chen JX, Pavon DL, Peckham AM. The crossroads of opioid use disorder, antimicrobial stewardship, and infection control: 5 things for pharmacists to know about harm reduction. IDSTEWARxDSHIP.com, 2019.
• Evoy KE, Covvey JR, Peckham AM, et al. Reports of gabapentin and pregabalin abuse, misuse, dependence, or overdose: an analysis of the Food and Drug Administration Adverse Events Reporting System (FAERS). Res Social Adm Pharm 2019;15:953-8.
• Storjohann T, Pogge E, Peckham AM, et al. Evaluation of a peer- and self-grading process for clinical writing assignments. Curr Pharm Teach Learn 2019;11:979-86.

Presentations

• Discua D, Duron RM, Arias C, Patterson C, Nguyen VH et al. Using data mining tools, microservices architecture and artificial intelligence modules for the “Juvenile Myoclonic Epilepsy JME-1000 Project.” Abstract 4656. Poster presented at: American Academy of Neurology 71st Annual Meeting; 2019; Philadelphia, PA.
• Silva R, Duron RM, Flores W, Siriani Y, Nguyen VH, et al. Progressive myoclonus epilepsy of Lafora first diagnosed in El Salvador. Abstract 4578 Poster presented at: American Academy of Neurology 71st Annual Meeting; 2019; Philadelphia, PA.
• Tanaka M, Martinez-Juarez IE, Duron RM, Nguyen VH, et al. Autophagy in juvenile myoclonic epilepsy. Abstract 3.02. Poster presented at: American Epilepsy Society Annual Meeting; 2019; Baltimore, MD.
• Peckham AM. Harm reduction and medications for opioid use disorder [podium presentation]. Presented at: Beth Israel Deaconess Medical Center Infectious Disease Conference on Research, Education, and Science; December 2019; Boston, MA.
• Peckham AM. The pharmacist’s role in increasing treatment access for patients with opioid use disorder [podium presentation]. Presented at: Massachusetts General Hospital Pharmacy Week; October 2019; Boston, MA.
• Evoy KE, Leonard CE, Covvey JR, Peckham AM, et al. MeRIT project: substance use disorder counseling among those taking opioid analgesics – an analysis of NAMCS data. Poster presented at: American College of Clinical Pharmacy; 2019 Annual Meeting; New York City.
• Patel J, Peckham AM. Use of buprenorphine injection following a “Bernese method” induction in a low threshold treatment program for a patient with substance use disorder: a case report. Poster presented at: American Society of Health-System Pharmacists Midyear Clinical Meeting; December 2019; Las Vegas, NV.

Other Notable Achievements

• Alyssa Peckham: Served as expert panelist in substance use disorders as part of Northeastern University’s Bouvé College of Health Sciences Health in Translation Event; January 2020; Boston, MA.

The Clinical Administration PRN has been developing current and future leaders through its programming. The Student and Resident Committee hosted its annual HSPA residency webinar and a presentation focused on networking at large meetings. The PRN is currently developing a journal club around administrative and leadership topics, spotlights on the variety of jobs in administration, and educational development guidance for staff pharmacists.

Promotions

• Lindsay Arnold: Assistant Professor of Medicine, Tufts University School of Medicine.
• Cindy Brasher: Manager of Compounding, St. Jude Children’s Research Hospital

Publications

• Engle JP, Dick TB, Bryant G, et al. Credentialing and privileging for clinical pharmacists. J Am Coll Clin Pharm 2020;3:133-44.
• Vest TA, Gazda NP. Develop productivity metrics. Pharmacy Purchasing and Products 2019;16:48.

Promotions

• Christine Groth: Clinical Pharmacy Coordinator-Adult Critical Care and Emergency Medicine, University of Rochester Medical Center.
• Md Jahidul Hasan: Coordinator of Clinical Pharmacy Services, Department of Pharmacy, Square Hospitals Ltd.
• Mojdeh Heavner: Vice Chair of Clinical Pharmacy Services, University of Maryland.
• Diana (Gritsenko) Lemieux: Clinical Pharmacy Specialist, Yale New Haven Hospital.
• Martin Ohlinger: Distinguished University Lecturer, University of Toledo College of Pharmacy and Pharmaceutical Sciences.
• Megan Rech: Research Coordinator, Department of Emergency Medicine, Loyola University Medical Center.
• Joshua Robinson: Academic Appointment – Assistant Clinical Professor of Pharmacy at UCSF School of Pharmacy.

Awards

• Elizabeth Beckman: Presidential Citation Award, Society of Critical Care Medicine.
• Sarah Blackwell: Service Award, Alabama Society of Health-System Pharmacists.
• Stacey Campbell: 2019 ACCP Critical Care PRN Clinical Practitioner Award.
• Chris Droege: 2019 ACCP Critical Care PRN Mentor of the Year Award.
• Sonia Everhart: Presidential Citation Award, Society of Critical Care Medicine.
• Alex Flannery: Rho Chi Alumni Award.
• Carrie Griffiths: Presidential Citation Award, Society of Critical Care Medicine.
• Christine Groth:
  Two Star Research Award Certificates of Achievement, Society of Critical Care Medicine.
  Presidential Citation Award, Society of Critical Care Medicine.
  2019 Adult Critical Care Excellence in Leadership Award, University of Rochester Medical Center.
• Curtis Haas: 2019 ACCP Critical Care PRN Achievement Award.
• Leslie Hamilton: Presidential Citation Award, Society of Critical Care Medicine.
• Drayton Hammond:
  Star Research Award Certificate of Achievement, Society of Critical Care Medicine.
  2019 ACCP Critical Care PRN Junior Investigator Award.
• Mojdeh Heavner: Presidential Citation Award, Society of Critical Care Medicine.
• Judith Jacobi: Distinguished Service Award, SCCM-CPP Section.
• Todd Miano: Presidential Citation Award, Society of Critical Care Medicine.
• Scott Mueller: 2019 ACCP Critical Care PRN Education Award.
• Megan Rech:
  Silver Star Research Award Certificate of Achievement, Society of Critical Care Medicine.
  Presidential Citation Award, Society of Critical Care Medicine.
  2019 ACCP Critical Care PRN Research Award.
• Joshua Robinson: Apple Award for Preceptor of Excellence, UCSF School of Pharmacy.
• Melanie Smith: 2019 ACCP Critical Care PRN Publication of the Year Award.

Grants

• Nicole Acquisto/Christine Groth: 2019 NYS ACCP Research Grant: “Pharmacists as Members of an Interdisciplinary Pulmonary Embolism Response Team (PERT).”
• Erin Barreto:
  National Institute of Allergy and Infectious Diseases (K23 AI 143882): “Beta-Lactam Individualization for Critically Ill Patients.”
  American Society of Health-System Pharmacists: “Use of Nephrotoxic Drugs in AKI Survivors at Transitions of Care: Risk for Chronic Kidney Disease.”
  Mayo Clinic Midwest Clinical Practice Committee Innovation Award for “AKI Survivorship Pilot-A Multiprofessional Approach to Care Transitions.”
• Scott Bolesta: Wilkes University Provost Research and Scholarship Grant: “Assessing Current Analgesia and Sedation Weaning Practices in Adult Critically Ill Patients.”
• Todd Miano: Penn Center for Precision Medicine Implementation Grant: “Development and Implementation of a Personalized Dosing Algorithm for Tacrolimus Immunosuppression After Lung Transplantation.”
• Susan Smith: AACP New Investigator Award.

Publications

• Wright C, Elbadawi A, Chen YL, Mazzillo J, Delehanty J, Patel D, Acquisto NM, Groth CM, et al. The impact of a pulmonary embolism response team on the efficiency of patient care in the emergency department. J Thromb Thrombolysis 2019;48:331-5.
• Barreto EF, Nemecek BD. Renal disease and renal replacement therapy overview. In: Nemecek BD, Hammond DA, eds. Demystifying Drug Dosing in Renal Dysfunction. Bethesda, MD: American Society of Health-System Parmacists, 2019:1-14.
• Barreto JN, Piche SL, Hogan BM, Barreto EF. Effect of a multimodal multidisciplinary training program on pharmacy residents’ knowledge and confidence toward research and biostatistics. Curr Pharm Teach Learn 2020;12:20-6.
• Kurani S, Hickson LJ, Thorsteinsdottir B, Barreto EF, et al. Supplement use by US adults with CKD: a population-based study. Am J Kidney Dis 2019;74:862-5.
• Kurani S, Jeffery MM, Thorsteinsdottir B, Hickson LJ, Barreto EF, et al. Use of potentially nephrotoxic medications by U.S. adults with chronic kidney disease: NHANES, 2011-2016. J Gen Intern Med 2019 Dec 2. [Epub ahead of print]
• Lam SW, Barreto EF, Scott R, et al. Cost-effectiveness of second-line vasopressors for the treatment of septic shock. J Crit Care 2020;55:48-55.
• Zhao Y, Seelhammer TG, Barreto EF, et al. Altered pharmacokinetics and dosing of liposomal amphotericin B and isavuconazole during extracorporeal membrane oxygenation. Pharmacotherapy 2020;40:89-95.
• Lange NW, Salerno DM, Berger K, et al. Management of hepatic coagulopathy in bleeding and non-bleeding patients: an evidence-based review. J Intensive Care Med 2020 Feb 21. [Epub ahead of print]
• Sigounas D, Moeini-Naghani I, Patsalides A, Greenberg E, Berger K, et al. Continuous intra-arterial infusion of verapamil for treatment of severe vasospasm after subarachnoid hemorrhage. Interdiscip Neurosurg 2019;19:100622.
• Berger K, Goldstein JN, O’Meara AMI, Peacock S. Emergency neurologic life support: status epilepticus. Neurocrit Care 2019. [In press]
• Berger K, Santibañez M, Lin L, et al. A low-dose 4F-PCC protocol for DOAC-associated intracranial hemorrhage. J Intensive Care Med 2019 Apr 14. [Epub ahead of print]
• Shusterman M, Grassl N, Berger K, et al. Prolonged activated partial thromboplastin time after prophylactic-dose unfractionated heparin in the post-operative neurosurgical setting: case series and management recommendations. J Thromb Thrombolysis 2020;49:153-8.
• Ellison CA, Blackwell SB. Acute hepatocellular injury associated with azithromycin. J Pharm Pract 2020 Jan 13. [Epub ahead of print]
• Buckley MS, Knutson KD, Agarwal SK, et al. Clinical pharmacist-led impact on inappropriate albumin utilization and costs in the critically ill. Ann Pharmacother 2020;54:105-12.
• Fitzmaurice MG, Wong A, Akerberg H, Avramovska S, Smithburger PL, Buckley MS, et al. Evaluation of potential drug-drug interactions in the intensive care unit: a systematic review and meta-analysis. Drug Saf 2019;42:1035-44.
• Cucci MD, Benken ST. Blood pressure variability in the management of hypertensive emergency: a narrative review. J Clin Hypertens 2019;21:1684-92.
• Cucci M, Wooten C, Fowler M, et al. Incidence and risk factors associated with multi-drug-resistant pathogens in a critically ill trauma population: a retrospective cohort study. Surg Infect (Larchmt) 2020;21:15-22.
• Flannery AH, Jones GM. Providing for wellness in residency program directors [letter]. Am J Health Syst Pharm 2020;77:162-3.
• Flannery AH, Moss M. Rescue neuromuscular blockade in ARDS should not be flat-dose. Crit Care Med 2019 Dec 17. [Epub ahead of print]
• Flannery AH, Soric MM, Benavides S, et al. 2019 update to the American College of Clinical Pharmacy Pharmacotherapy Didactic Curriculum Toolkit. J Am Coll Clin Pharm 2019;3:455-64.
• Gregory ER, Burgess DR, Cotner SE, VanHoose JD, Flannery AH, et al. Pharmacist survey: pharmacist perception of vancomycin area under the curve therapeutic drug monitoring. J Pharm Pract 2019 Aug 18. [Epub ahead of print]
• Nichols DC, Flannery AH, Magnuson B, Cook AM. Prealbumin is associated with in-hospital mortality in critically ill patients. Nutr Clin Pract 2019 Sep 23. [Epub ahead of print]
• Groth CM, Johnson A, Resendiz K, et al. Unique challenges of anticoagulation of pediatric patients. Society of Critical Care Medicine Clin Pharm Pharmacol Newsl 2019;19(suppl 5):2.
• Haan BJ, Cadiz ML, Natavio AM. Efficacy and safety of vasopressin as first-line treatment of distributive and hemorrhagic shock states. Ann Pharmacother 2020;54:213-8.
• Hamilton LA, Guarascio AJ. Tetracycline allergy. Pharmacy (Basel) 2019;7:104.
• Hamilton LA, Suda KJ, Heidel RE, et al. The role of online learning in pharmacy education: a nationwide survey of student pharmacists. Curr Pharm Teach Learn 2020. [In press]
• Bader MK, Blissitt PA, Hamilton LA, et al. Clinical Q&A: translating therapeutic temperature management from theory to practice. Ther Hypothermia Temp Manag 2019;9:163-5.
• Fontaine GV, Der Nigoghossian C, Hamilton LA. Melatonin, ramelteon, suvorexant, and dexmedetomidine to promote sleep and prevent delirium in critically ill patients: a narrative review with practical applications. Crit Care Nurs Q 2020. [In press]
• Tatro HA, Hamilton LA, Peters C, et al. Identification of risk factors for refractory status epilepticus. Ann Pharmacother 2020;54:14-21.
• Hammond DA, Lam SW, Rech MA, Smith MN, et al. Balanced crystalloids versus saline in critically ill adults: a systematic review and meta-analysis. Ann Pharmacother 2020;54:5-13.
• Hammond DA, Peksa GD, Rech MA. Balanced crystalloids in sepsis: are we there yet? Am J Respir Crit Care Med 2020 Jan 23. [Epub ahead of print]
• Hammond DA, Rech MA. A “how-to” guide for effectively writing a publishable research manuscript. J Am Coll Clin Pharm 2019;1-7.
• Hammond DA, Rech MA. Cautions heeded: a call to action for evaluating pharmacists’ direct and indirect patient care activities [letter]. J Am Coll Clin Pharm 2020;3:546-7.
• Hammond DA, Swanson J, Rech MA. The effect of grit on postgraduate year-one pharmacy residents’ pursuit of additional training. Curr Pharm Teach Learn. [In press]
• Hammond DA, Swanson J, Rech MA. The effect of burnout on postgraduate year-one pharmacy residents’ pursuit of additional training. J Am Coll Clin Pharm 2020;1-8.
• Barlow BL, Barlow AP, Hammond DA. Identifying different types of professional relationships: are you my mentor? Am J Health Syst Pharm. [In press]
• Benken S, Madrzyk E, Chen D, Lopez J, Schmelzer D, Sessions Z, Patel G, Hammond DA. Hemodynamic effects of propofol and dexmedetomidine in septic patients without shock. Ann Pharmacother. [In press]
• Eudaley ST, Mihm AE, Hammond DA, et al. Characterization of clinical knowledge and problem-solving assessments employed in post-graduate year one (PGY1) pharmacy residency interviews. Am J Health Syst Pharm. [In press]
• Khan A, DeMott JD, Varughese C, Hammond DA. Effect of cefepime on neurotoxicity development in critically ill adults with renal dysfunction. Chest. [In press]
• Hasan MJ. The contribution of square hospital in the establishment of hospital pharmacovigilance in Bangladesh: a practice role model. Stamford J Pharm Sci. [In press]
• Hasan MJ. Drug use during pregnancy: safety matters. Pharma World 2019;11:92-6.
• Hasan MJ. Polymyxins nebulization over intravenous injection: pharmacokinetics and pharmacodynamics-based therapeutic evaluation. J Pharm Res Int 2018;25:1-10.
• Hasan MJ, Hosen MS, Bachar SC. The resistance growing trends of common gram-negative bacteria against the potential antibiotics: a study in Bangladesh. Pharm Pharmacol Int J 2019;7:114-9.
• Hasan MJ, Rabbani R, Bachar SC. Severe hypoalbuminemia increases the risk of thrombocytopenia in critically ill adult patients receiving teicoplanin. Dhaka Univ J Pharm Sci 2019;18:153-7.
• Hasan MJ, Rabbani R, Bachar SC. Clinical interventions of critical care pharmacist in the therapeutic management of critically ill patients: a retrospective study in Bangladesh. Dhaka Univ J Pharm Sci 2019;18:113-9.
• Hasan MJ, Rabbani R, Bachar SC. Evaluation of the therapeutic effectiveness of polymyxin B versus colistin in carbapenem-resistant Klebsiella pneumoniae-associated bacteremia. Dhaka Univ J Pharm Sci 2019;18:209-15.
• Hasan MJ, Rabbani R, Bachar SC. Therapeutic specification of the last resort polymyxins: an intelligent approach. Int J Infect 2019;6:e96828.
• Hasan MJ, Rabbani R, Huq SMR. High dose eltrombopag in the effective and safe management of sepsis-associated thrombocytopenia in critically ill patients. J Crit Care Med 2019;5:123-9.
• Hasan MJ, Rabbani R, Huq SMR, et al. Tigecycline in CR-Kp associated VAP with high dose versus conventional dose: adverse events are the key superiority-determiner. Adv Pharmacoepidemiol Drug Saf 2019;8:227.
• Hasan MJ, Rabbani R, Huq SMR, et al. High dose tigecycline-induced mitochondrial dysfunction-associated acute metabolic acidosis: a retrospective study. J Mol Genet Med 2019;13:407.
• Hosen MS, Hasan MM, Islam MS, Raseduzzaman MM, Islam MT, Hossain MM, Nafiujjaman M, Nishat TR, Hasan MJ. Evaluation of knowledge and practice of handling chemotherapeutic agents by nurses: a multi-center study in Bangladesh. Int J Commun Med Public Health 2019;6:4175-80.
• Jacobi J. Glucose control and insulin therapy for critical illness hyperglycemia: into the 3rd decade. In: Current Concepts in Adult Critical Care 2020. Mount Prospect, IL: Society for Critical Care Medicine, 2020:97-112.
• Jacobi J. How do critical care pharmacists contribute to team-based care? In: Deutschman CS, Neligan PJ, eds. Evidence-Based Practice of Critical Care, 3rd ed. Philadelphia: Elsevier, 2020:612-7.
• Jacobi J. Perspectives on mentorship. Crit Connect Newsl SCCM Summer 2019.
• Jarrell AS. Acute abdomen and abdominal sepsis. In: Boucher BA, Haas CE, eds. Critical Care Self-Assessment Program, 2019 Book 2. Surgical Patients in the ICU. Lenexa, KS: American College of Clinical Pharmacy, 2019:129-58.
• Lindner BK, Gilmore VT, Kruer RM, Alvanzo AA, Chen ES, Murray P, Niessen T, Perrin K, Rastegar DA, Young S, Jarrell AS. Evaluation of the Brief Alcohol Withdrawal Scale protocol at an academic medical center. J Addict Med 2019;13:379-84.
• Miano TA, Flesch JD, Feng R, et al. Early tacrolimus concentrations after lung transplant are predicted by combined clinical and genetic factors and associated with acute kidney injury. Clin Pharmacol Ther 2020;107:462-70.
• Miano TA, Yang W, Shashaty MGS, et al. The magnitude of the warfarin-amiodarone drug-drug interaction varies with renal function: a propensity-matched cohort study. Clin Pharmacol Ther. [In press]
• Anderson BJ, Calfee CS, Liu KD, Reilly JP, Kanngelaris KN, Shashaty MGS, Lazaar AL, Bayliffe AI, Gallop RJ, Miano TA, et al. Plasma sTNFR1 and IL8 for prognostic enrichment in sepsis trials: a prospective cohort study. Crit Care 2019;23:400.
• Merkel A, Massey K, Bellamy C, Miano TA, et al. Predictors of cisatracurium continuous infusion dose in acute respiratory distress syndrome. J Pharm Pract 2019 Nov 18. [Epub ahead of print]
• Minhaj FS, Anderson BD, King JD, et al. Outcomes of acute exploratory pediatric lithium ingestions. J Clin Toxicol 2020 Jan 8. [Epub ahead of print]
• Minhaj FS, Hoang-Nguyen M, Tenney A, et al. Evaluation of opioid requirements in the management of renal colic after guideline implementation in the emergency department. Am J Emerg Med 2019 Dec 23. [Epub ahead of print]
• Rech MA. Oseltamivir for all: should it become an over-the-counter medication for influenza treatment? Pharmacotherapy 2020 Feb 12. [Epub ahead of print]
• Colon Hidalgo D, Patel J, Masic D, Park D, Rech MA. Delayed vasopressor initiation is associated with increased mortality in patients with septic shock. J Crit Care 2020;55:145-8.
• Finn RM, Kule A, Young K, Rech MA. Impact of pre-admission vitamin D supplementation on mortality in septic patients [letter]. J Intensive Care Soc 2019 Dec 18. [Epub ahead of print]
• Koch E, Lovett S, Nghiem T, Riggs RA, Rech MA. Shock index in the emergency department: utility and limitations. Open Access Emerg Med 2019;11:179-99.
• Lamparter LE, Rech MA, Nguyen TM. Homeless patients tend to have greater psychiatric needs when presenting to the emergency department. Am J Emerg Med 2019 Nov 18. [Epub ahead of print]
• Monzon B, Hegarty K, Rech MA. A knack for “NAC”: treatment for heat stroke induced acute liver injury: a case report. Am J Emerg Med 2019 Nov 28. [Epub ahead of print]
• Peksa GD, Mokszycki RK, Rech MA, et al. Reversal of warfarin-associated major hemorrhage: activated prothrombin complex concentrate versus 4-factor prothrombin complex concentrate. Thromb Haemost 2020;120:207-15.
• Saffaei D, Lovett S, Rech MA. New-onset seizure in patient medicated with bupropion for smoking cessation: a case report. J Emerg Med 2020 Jan 27. [Epub ahead of print]
• Zavala S, Larson J, O’Mahony M, Rech MA. Impact of insufficient admission vitamin D serum concentrations on sepsis incidence and clinical outcomes in patients with thermal injury. Burns. [In press]
• Robinson JD, Caruso TJ, Wu M, et al. Intraoperative methadone is associated with decreased perioperative opioid use without adverse events: a case-matched cohort study. J Cardiothorac Vasc Anesth 2020;34:335-41.
• Santibañez M, Bunnell K, Harrington A, et al. Association between pharmacokinetic/pharmacodynamic derived predictions of efficacy and clinical outcomes in obese and non-obese patients with Enterobacteriaceae bloodstream infections. Open Forum Infect Dis 2019;6:ofz400.
• Boylan PM, Santibañez M. Case report of upper gastrointestinal bleeding in a male patient taking rivaroxaban and megestrol acetate. Sr Care Pharm 2019;34:501-9.
• Boylan PM, Sedlacek J, Santibañez M, et al. Development and implementation of interprofessional relations between a college of pharmacy and osteopathic residency programs in a community teaching hospital. J Pharm Technol 2020;36:3-9.
• Daniels C, Santibañez M. Diversity considerations in selecting a residency program. In: Caballero J, Benavides S, Clauson KA, eds. Get the Residency: ASHP’s Guide to Residency Interviews and Preparation, 2nd ed. Bethesda, MD: American Society of Health-System Pharmacists, 2019:85-96.
• Smith SE, Muir J, Kalabalik J. Procalcitonin in special patient populations: guidance for antimicrobial therapy. Am J Health Syst Pharm 2019. [In press]
• Smith SE, Sikora Newsome A, Hawkins WA, et al. Teaching research skills to student pharmacists: a multi-campus, multi-semester applied critical care research elective. Curr Pharm Teach Learn 2019. [In press]
• Jones TW, Finder S, Sikora Newsome A, Smith SE. Getting to the heart of the matter: what we know about fluid resuscitation in septic heart failure patients. Crit Care Med 2019. [In press]
• Jones TW, Sikora Newsome A, Smith SE, Forehand C. Interprofessional shared decision-making: who is at the table? Crit Care Med 2020;48:e158-9.
• Newsome AS, Smith SE, Olney WJ, et al. Medication regimen complexity is associated with pharmacist interventions and drug-drug interactions: a use of the novel MRC-ICU scoring tool. J Am Coll Clin Pharm 2020;3:47-56.
• Sikora Newsome A, Jones TW, Smith SE. Pharmacists are associated with reduced mortality in critically ill patients: now what? Crit Care Med 2019;47:e1036-7.
• Sikora Newsome A, Smith SE Author reply to “Significant correlation versus strength of correlation.” Am J Health Syst Pharm 2019. [In press]

New Fellows

• Teresa Allison: FCCM – American College of Critical Care Medicine.
• Heather Bullard: FCCM – American College of Critical Care Medicine.
• Jennifer Cole: FCCP – American College of Clinical Pharmacy.
• Sonia Everhart: FCCM – American College of Critical Care Medicine.
• Alex Flannery: FCCM – American College of Critical Care Medicine.
• Jaime Gray: FCCM – American College of Critical Care Medicine.
• Christine Groth: FCCM – American College of Critical Care Medicine.
• Drayton Hammond: FCCM – American College of Critical Care Medicine.
• Mojdeh Heavner: FCCM – American College of Critical Care Medicine.
• Lamis Karaoui: FCCP – American College of Clinical Pharmacy.
• Kimberly Levasseur-Franklin: FCCM – American College of Critical Care Medicine.
• Paul O’Donnell: FCCM – American College of Critical Care Medicine.
• Mona Patel: FCCM – American College of Critical Care Medicine.
• Megan Rech: FCCM – American College of Critical Care Medicine.
• Garrett Schramm: FCCP – American College of Clinical Pharmacy.
• Jeffery Spray: FCCM – American College of Critical Care Medicine.
• Todd Walroth: FCCM – American College of Critical Care Medicine.
• Lisa Hall Zimmerman: FCCP – American College of Clinical Pharmacy.

Other Notable Achievements

• Erin Barreto: Chair, SCCM CPP Section.
• Elizabeth Beckman: Vice Chair, Education Committee – ACCP Pediatrics PRN.
• Karen Berger: DAL-Elect, ASHP Section of Clinical Specialists and Scientists Executive Committee; Member-at-Large, SCCM CPP Section.
• Sarah Blackwell: Council Director of Organizational Affairs, Alabama Society of Health-System Pharmacists.
• Scott Bolesta: Chair, SCCM Research Section.
• Mitchell Buckley: Chair, Practice Advancement Committee – SCCM CPP Section.
• Stephen Chromi: Director, NVSHP Public Relations.
• Alex Flannery: Chair-Elect, ACCP Critical Care PRN; Chair-Elect, Research and Scholarship Committee – SCCM CPP Section; Vice Chair, ACCP Research Affairs Committee; Editorial Board, Annals of Pharmacotherapy.
• Jeffrey Fong: Chair, ACCP Critical Care PRN.
• Jeff Gonzales: Chair-Elect, SCCM CPP Section.
• Carrie Griffiths: President, SCCM Carolina/Virginia Chapter; BPS Critical Care Council.
• Christine Groth: Chair, Recognition Committee – ACCP Critical Care PRN; Chair-Elect, Practice Advancement Committee – SCCM CPP Section.
• Bradley Haan: BCCCP.
• Leslie Hamilton: Secretary of Knowledge Management, AACP-Pharmacy Practice Section; Secretary/Treasurer, ACCP Critical Care PRN.
• Drayton Hammond: Member-at-Large, SCCM CPP Section.
• Md Jahidul Hasan: Program-Coordinator, Antimicrobial Stewardship Program (ASP), Square Hospitals Ltd, Dhaka, Bangladesh; Fellowship training course: International Course on Antibiotics and Resistance (ICARe), Annecy, France, from Institut Pasteur.
• Mojdeh Heavner: Associate Editor, American Journal of Health-System Pharmacy.
• Diana (Gritsenko) Lemieux: BCCCP; Committee Member, SCCM Accreditation and Learning Strategies Committee.
• Kimberly Levasseur-Franklin: PGY2 Critical Care Residency Program Director, Tufts Medical Center.
• Jerika Nguyen: BCCCP.
• Joshua Robinson: Founding Chair, Pediatric Pharmacy Association-Cardiology SIG.
• Melissa Santibañez: BCCCP; Chair, Membership Committee-SCCM Florida Chapter.
• Susan Smith: Chair-Elect, Communications Committee-SCCM CPP Section.
• Zachary Smith: PGY2 Critical Care Residency Program Director, Henry Ford Hospital.
• Joanna Stollings: Secretary/Treasurer, SCCM CPP Section.

Grants

• Ajna Hamidovic (Principal Investigator): NIH/NIMH grant for “Late Luteal Phase Reactivity to Stress.” PHASE (Premenstrual Hormonal and Affective State Evaluation) Study. Grant R21MH119642. Project period: 09/26/2019 – 06/30/2021. University of Illinois at Chicago ($439,725).

Publications

• Elias A, Pepin MJ, Brown JN. Adjunctive memantine for opioid use disorder treatment: a systematic review. J Subst Abuse Treat 2019;107:38-43.
• Jacob S, VanDeale MA, Brown JN. Treatment of Demodex-associated inflammatory skin conditions: a systematic review. Dermatol Ther 2019;32:e13103.
• Lee S, Sneed GT, Brown JN. Nitazoxanide-based treatments for Helicobacter pylori: a systematic review. Infect Dis (Lond) 2020 Jan 3. [Epub ahead of print]
• Smith KR, Bryan WE, Townsend ML, Randolph AE, Vanderman AJ, Woodard CL, Brown JN. Impact of prophylactic oseltamivir on INR in patients on stable warfarin therapy. J Thromb Thrombolysis 2020 Jan 2. [Epub ahead of print]
• Sneed GT, Lee S, Brown JN, et al. The role of pazopanib in non-clear cell renal cell carcinoma: a systematic review. Clin Genitourin Cancer 2019;17:419-24.
• Nguyen CB. The use of serious gaming to assess drug information skills. J Am Coll Clin Pharm 2020;3:473-7.
• Nguyen CB. The role of a pharmacist as a medical information specialist in the pharmaceutical industry. Curr Pharm Teach Learn 2020;12:127-31.
• Phillips J, Hanrahan C, Brown JN, May D, Britnell SR, Ficzere C. Guiding principles for evaluating tertiary health care resources: the A2C2QUIRE framework. J Am Coll Clin Pharm 2020;3:485-93.
• Rodriguez R, Koppen L, Patel YA, et al. Characteristics of shortage-related drug information requests and recommendations from a nationally serving drug information center. Am J Health Syst Pharm 2019;76:1900-2.
• Rodriguez R, Touchette D. In: Murphy JE, Lee MW, eds. Pharmacotherapy Self-Assessment Program, 2020 Book 1. Critical and Urgent Care. Lenexa, KS: American College of Clinical Pharmacy, 2020:221-5.
• Rodriguez R, Touchette DR. Part II: statistics in practice: statistics overview. J Am Coll Clin Pharm 2020;1-6.

Promotions

• Megan Rech: Research Coordinator; Department of Emergency Medicine, Loyola University Medical Center.

Awards

• Tuqa Alkhateeb:
  Star Research Achievement Award, Society of Critical Care Medicine.
  Trainee Travel Award, Midwest Clinical and Translational Research Meeting.
• Megan Rech:
  Presidential Citation Award, Society of Critical Care Medicine.
  Silver Star Research Award Certificate of Achievement, Society of Critical Care Medicine.

Grants

• Rynn KO:
  Rynn KO, Schriever C, Hayes A: Residency Expansion Grant. ASHP Foundation $25,000, 2020.
  Rynn KO, Smith KE, Schaefer C, Hemenway A: “Investing in the Recruitment and Retention of Top Talent to the Profession of Pharmacy.” Community Foundation of Northern Illinois with support from the Dr. Louis and Violet Rubin Foundation $38,870, 2018–2020.

Publications

• Anderson GL, Mattson AE, Brown CS, et al. Safety of parenteral ketorolac use for analgesia in geriatric emergency department patients. Am J Emerg Med 2019 Jun 6. [Epub ahead of print]
• Anderson GL, Olson OJ, Mannenbach MS, Rudis MI. Pediatric emergency department interventions of pharmacy residents. Pediatr Emerg Care 2020 Jan 20. [Epub ahead of print]
• Anderson GL, Osborn JL, Nei SD, et al. Comparison of in-hospital bleeding and cardiovascular events with high-dose bolus tirofiban and shortened infusion to short-duration eptifibatide as adjunctive therapy for percutaneous coronary intervention. Am J Cardiol 2019;123:44-9.
• Holder MC, Bailey AM, Baum RA, Justice SB, Weant KA. Assessment of dose capping phenytoin loading practices in the emergency department and the impact of an emergency medicine pharmacist. J Am Coll Clin Pharm 2019;2:633-7.
• Patel GP, Hyland SJ, Birrer KL, et al. Perioperative clinical pharmacy practice: responsibilities and scope within the surgical care continuum. J Am Coll Clin Pharm 2020;3:501-19.
• Lamkin L, Lindsey S, Weant K, et al. Implications of the presence of an emergency medicine pharmacist during critical care trauma patient resuscitation. J Am Coll Clin Pharm 2019;2:251-6.
• Peksa GD, Mokszycki RK, Rech MA, et al. Reversal of warfarin-associated major hemorrhage: activated prothrombin complex concentrate versus 4-factor prothrombin complex concentrate. Thromb Haemost 2020;120:207-15.
• Hammond DA, Peksa GD, Rech MA. Balanced crystalloids in sepsis: are we there yet? Am J Respir Crit Care Med 2020 Jan 23. [Epub ahead of print]
• Rech MA. Oseltamivir for all: should it become an over-the-counter medication for influenza treatment? Pharmacotherapy 2020 Feb 12. [Epub ahead of print]
• Colon Hidalgo D, Patel J, Masic D, Park D, Rech MA. Delayed vasopressor initiation is associated with increased mortality in patients with septic shock. J Crit Care 2020;55:145-8.
• Finn RM, Kule A, Young K, Rech MA. Impact of pre-admission vitamin D supplementation on mortality in septic patients [letter]. J Intensive Care Soc 2019 Dec 18. [Epub ahead of print]
• Hammond DA, Lam SW, Rech MA, et al. Balanced crystalloids versus saline in critically ill adults: a systematic review and meta-analysis. Ann Pharmacother 2020;54:5-13.
• Hammond DA, Rech MA. Cautions heeded: a call to action for evaluating pharmacists’ direct and indirect patient care activities [letter]. J Am Coll Clin Pharm 2020;3:546-7.
• Hammond DA, Rech MA. A “how-to” guide for effectively writing a publishable research manuscript. J Am Coll Clin Pharm 2019;1-7.
• Hammond DA, Swanson J, Rech MA. The effect of grit on postgraduate year-one pharmacy residents’ pursuit of additional training. Curr Pharm Teach Learn 2020;12:112-8.
• Hammond DA, Swanson J, Rech MA. The effect of burnout on postgraduate year-one pharmacy residents’ pursuit of additional training. J Am Coll Clin Pharm 2019 Dec 25. [Epub ahead of print]
• Koch E, Lovett S, Nghiem T, Riggs RA, Rech MA. Shock index in the emergency department: utility and limitations. Open Access Emerg Med 2019;11:179-99.
• Lamparter LE, Rech MA, Nguyen TM. Homeless patients tend to have greater psychiatric needs when presenting to the emergency department. Am J Emerg Med 2019 Nov 18. [Epub ahead of print]
• Monzon B, Hegarty K, Rech MA. A knack for “NAC”: treatment for heat stroke induced acute liver injury: a case report. Am J Emerg Med 2019 Nov 28. [Epub ahead of print
• Saffaei D, Lovett S, Rech MA. New-onset seizure in patient medicated with bupropion for smoking cessation: a case report. J Emerg Med 2020 Jan 27. [Epub ahead of print]
• Zavala S, Larson J, O’Mahony M, Rech MA. Impact of insufficient admission vitamin D serum concentrations on sepsis incidence and clinical outcomes in patients with thermal injury. Burns. [In press]
• Thomas MC. Simulation in pharmacy education. J Am Coll Clin Pharm 2019;2:608-9.
• Hall PD, Fish H, McBane S, Mercer J, Moreau C, Owen J, Policastri AA, Rattinger GB, Srivastava SB, Thomas MC, et al. The report of the 2018-2019 Professional Affairs Standing Committee: the role of educators in pharmacy practice transformation. Am J Pharm Educ 2019;83:7596.
• Covvey JR, Arya V, DiPietro Mager N, Gilman N, Herring M, Lukas S, Ochs L, Waddington L, eds. Public Health in Pharmacy Practice: A Casebook, 1st ed. Genesco, NY: Open SUNY Textbooks, 2020.
• Conliffe B, VanOpdorp J, VanArsdlae V, Brown J, Weant K, et al. Impact of an advanced pharmacy practice experience (APPE) student-run “Meds 2 Beds” and discharge counseling program on quality of care. Hosp Pharm 2019;54:314-22.
• Patanwala AS, Weant KA, Acquisto N. Feasibility of pharmacists to contribute to multicenter emergency medicine research. J Am Coll Clin Pharm 2019;2:681-5.
• Smith MN, Deloney L, Carter C, Weant KA, et al. Safety, efficacy, and cost of four-factor prothrombin complex concentrate (4F-PCC) in patients with factor Xa inhibitor-related bleeding: a retrospective study. J Thromb Thrombolysis 2019;48:250-5.
• Yarbrough N, Bloxam M, Priano J, Louzon P, Hunt LN, Elfman J. Pharmacist impact on sepsis bundle compliance through participation on an emergency department sepsis alert team. Am J Emerg Med 2019;37:762-3.

Other Notable Achievements

• Megan Rech: Fellow of the American College of Critical Care Medicine.

Publications

• Bzowyckyj AS, Aquilante CL, Cheng AL, et al. Leveraging the electronic medical record to identify predictors of non‐attendance to a Diabetes Self‐Management Education and Support (DSMES) program. Diabetes Educ 2019;45:544‐52.
• Dixon DL, Salgado TM, Luther JM, et al. Medicare reimbursement policy for ambulatory blood pressure monitoring: a qualitative analysis of public comments to the Centers for Medicare & Medicaid Services. J Clin Hypertens 2019;21:1803‐9.
• Dixon DL, Virani SS. Mortality reduction with PCSK9 inhibition: a case of cautious optimism [invited editorial]. J Clin Lipidol 2019;13:712‐3.
• Dixon DL, Wohlford GF, Abbate A. Inflammation and hypertension: causal or not? [invited editorial]. Hypertension 2020;75:297-8.
• Bucheit J, Pamulapati LG, Carter NM, Malloy K, Dixon DL, et al. Oral semaglutide: a review of the first oral glucagon‐like peptide‐1 receptor agonist. Diabetes Technol Ther 2020;22:10-8.
• Del Buono MG, Bonaventura A, Vecchié A, Wohlford GF, Dixon DL, et al. Sacubitril‐valsartan for the treatment of heart failure: time for a paragon? [invited editorial]. J Cardiovasc Pharmacol 2020;75:105-7.
• Gipson GT, Carbone S, Wang J,Dixon DL, et al. Impaired delivery of cholesterol effluxed from macrophages to hepatocytes by serum from CKD patients may underlie increased cardiovascular disease risk. Kidney Int Rep 2020;5:199-210.
• Jia X, Ramsey DJ, Rifai MA, Ahmed ST, Akeroyd JM, Dixon DL, et al. Impact of lipid monitoring on treatment intensification of cholesterol lowering therapies (from the Veterans Affairs Healthcare System). Am J Cardiol 2020;125:874-9.
• Lajthia E, Nadpara PA, Dixon DL, et al. Combination therapy of once‐weekly glucagon like peptide‐1 receptor agonists and dipeptidyl peptidase‐4 inhibitors in type 2 diabetes: a retrospective case series. Pharm Pract 2019;17:1588.
• Robinson JG, Jayanna MB, Brown AS, Aspry K, Orringer C, Gill EA, Goldberg A, Jones LK, Maki K, Dixon DL, et al. Enhancing the value of PCSK9 monoclonal antibodies by identifying patients most likely to benefit. J Clin Lipidol 2019;13:525‐37.
• Salgado TM, Patterson J, Bajaj S, Lajthia E, Zimmerman K, Fernandez‐Llimos F, Dixon DL. Characterization of pharmacy practice research centers across the United States. Res Social Adm Pharm 2020;16:230-7.
• Wiggins BS, Dixon DL, Bellone J, et al. Key articles and guidelines in the management of dyslipidemia: 2019 update. J Pharm Pract 2019 Aug 11. [Epub ahead of print]
• Longo SL, Ryan JM, Sheehan KB, Reid DJ, et al. B(12) smart about monitoring: an evaluation of vitamin B12 monitoring in patients on metformin in urban ambulatory care settings. Pharm Pract 2019;17:1499.
• Rose TN, Jacobs ML, Reid DJ, et al. Real‐world impact on monthly glucose‐lowering medication cost, HbA1c, weight, and polytherapy after initiating a GLP‐1 receptor agonist. J Am Pharm Asso 2020;60:31-8.e1.
• Schumacher C, Van Dril E. Planning and steps to building the ambulatory patient care practice model. In: Kliethermes MA, Brown TR, eds. Building a Successful Ambulatory Care Practice: Advancing Patient Care. Bethesda, MD: American Society of Health‐System Pharmacists, 2019:41‐79.
• Schumacher C, Van Dril E. Clinical pharmacist’s role in heart failure management and the expansion of clinical pharmacist services in health care reform. In: Castelli G, ed. ACCP Ambulatory Care Pharmacist’s Survival Guide. 4th ed. Lenexa, KS: American College of Clinical Pharmacy, 2019:125‐37.

Posters

• Benjamin T, Schumacher C, Buros Stein A. Characterization of risk factors for genitourinary infections with sodium glucose cotransporter‐2 inhibitors (CORGI‐SGLT2i). Poster presented at: American College of Clinical Pharmacy Annual Meeting; October 2019; New York, NY.
• Van Dril E, Schumacher C, Kliethermes MA, Borchert J, et al. Workload evaluation of clinical pharmacists in the ambulatory care setting (WORK‐AC). Poster presented at: American College of Clinical Pharmacy Annual Meeting; October 2019; New York, NY.

Other Notable Achievements

• Mandy Blackford: Board Certified Pharmacotherapy Specialist (BCPS).
• Adam Bzowyckyj: Tradition of Excellence Award at the University of Connecticut School of Pharmacy.
• Diana Isaacs: Pharmacist Representative to the American Diabetes Association (ADA) Professional Practice Committee.
• Lara Kerwin: Board Certified Ambulatory Care Pharmacist (BCACP).
• Debra Reid: Fellow of the American Association of Diabetes Educators (FAADE).
• Christie Schumacher: Board Certified Cardiology Pharmacist (BCCP); Fellow of the American College of Clinical Pharmacy (FCCP).
• Liz Van Dril: Board Certified Ambulatory Care Pharmacist (BCACP).
• Megan Wesling: Board Certified Ambulatory Care Pharmacist (BCACP).

Presentations

• Gregory J. Hughes: Puff path to lung injury: a case of lipoid pneumonia due to e-cigarette or vaping product use-associated lung injury [poster]. (Also accepted as a finalist in the clinical vignettes category at the Society of Hospital Medicine’s Annual Conference; April 15–18; San Diego, CA.)

Publications

• Chen JJ. Sports ministry. Christianity Pharm 2019;22:3-4.
• Chen JJ. Mountain shift. Theology 2019;122:439.
• Chen JJ, Johannesmeyer H. Gagné’s nine events of instruction with active learning: teaching student pharmacists how to measure blood pressure. J Pharm Pract 2019 Sep 16. [Epub ahead of print]
• Cauffield JS, Chen JJ. Neurological conditions. In: Hume A, Orr K, eds. Principles and Practice of Botanicals as an Integrative Therapy. Boca Raton, FL: CRC Press. Taylor & Francis, 1st ed. 2019:203-20.
• Clifford KM, Grelle J, Tawwater JC, et al. Management of extended spectrum beta-lactamase producing Enterobacteriaceae urinary tract infections in the long-term care setting. Sr Care Pharm 2019;34:645-59.
• Ashraf MS, Gaur S, Bushen OY, Chopra T, Chung P, Clifford KM, et al. Diagnosis, treatment, and prevention of urinary tract infections in post-acute and long-term care settings: a consensus statement from AMDA’s infection advisory subcommittee. JAMDA 2020;21:12-24.
• Elbeddini A, Zhang C. The pharmacist’s role in successful deprescribing through hospital medication reconciliation. Can Pharm J 2019;152:177-9.
• Mulligan E, Tuff R, Leclair J, Mcmillan J, Devin B, Elbeddini A, et al. Implementation of a closed-loop medication reconciliation process for ambulatory oncology patients at Winchester District Memorial Hospital. Healthc Manage Forum 2019;33:85-9.
• Momin JH, Hughes GJ. Andexanet alfa (Andexxa) for the reversal of direct oral anticoagulants. P T 2019;44:530-49.
• Choy M, Kaufman MB. Healthcare Heroes: The Medical Careers Guide. Medina, OH: Sigel Press, 2019.
• Lee JK, Tomasa L, Evans P, et al. Impact of elective courses at three colleges of pharmacy: attitudes toward aging and eldercare. Curr Pharm Teach Learn 2019;11:1239-47.
• Almutairi A, Mollon L, Lee JK, et al. A comparison of the pharmacological and non-pharmacological strategies used to manage chronic pain: opioid users versus non-users. J Am Pharm Assoc 2019;59:691-7.
• Brooks A, Chen MK, Goldblatt E, Klatt M, Kilgore B, Koithan M, Kreitzer MJ, Lee JK, et al. Introducing integrative primary health care to an interprofessional audience: feasibility and impact of an asynchronous online course. Explore (NY) 2019 Aug 12. [Epub ahead of print]
• Campbell AM, Axon DR, Martin JR, Slack MK, Mollon L, Lee JK. Melatonin for the prevention of postoperative delirium in older adults: a systematic review and meta-analysis. BMC Geriatr 2019;19:1-10.
• Mizokami F, Mizuno T, Kanamori K, Oyama S, Nagamatsu T, Lee JK, et al. Clinical medication review type III of polypharmacy reduced unplanned hospitalizations in older adults: a meta-analysis of randomized clinical trials. Geriatr Gerontol Int 2019;19:1275-81.
• Shaw SJ, Korchmaros JD, Huebner Torres C, Totman M, Lee JK. The RxHL study: community responsive research to explore barriers to medication adherence. Health Educ Res 2019;34:556-68.
• Lisi DM. Precision medicine and Alzheimer’s, Parkinson’s, and Huntington diseases: from pathogenesis to emerging therapeutics, Power-Pak C.E.: Continuing Education for Pharmacists & Pharamcy Technicians. January 1, 2020.
• Silva Almodóvar A, Nahata MC. Potentially harmful medication use among medicare patients with heart failure. Am J Cardiovasc Drugs 2020 Feb 21. [Epub ahead of print]
• Bingham J, Silva Almodóvar A, Lee H, et al. The role of the pharmacist in mental health: an investigation of the impact of pharmacist-led interventions on psychotropic medication adherence in patients with diabetes. J Am Pharm Assoc 2020 Feb 26. [Epub ahead of print]

Grants

• Jeannie K. Lee: “Improving Hypertension Medication Adherence for Older Adults Source: NIH-NINR R01NR018469-01A1 Goal: To Advance and Test Medication Education, Decision Support, Reminding, and Monitoring System 2.0 (MEDSReM-2), a Theory-Based, Technology-Enhanced Comprehensive Self-Management System That Supports Hypertension Medication Adherence and Blood Pressure Management for Older Adults.” Role: Contact PI (MPI with Wendy Rogers, University of Illinois – Urbana Champaign). Amount: $3,092,027. Date: February 2020 – December 2024.

Promotions

• Jeff Sherer: Clinical Professor, University of Houston College of Pharmacy.

Awards

• Donna M. Lisi: ACCP Pharmacogenomics Certificate program completion.

Other Notable Achievements

• Stephanie M. Crist:
  Clinical Pharmacist Specialist, Mercy Clinics – East Community, St. Louis, Missouri.
  Owner and Senior Care Pharmacist Consultant, Silver Lining Pharmacy Consulting LLC.
• Ali Elbeddini:
  Canadian Health Care Executive Certificate from Canadian College of Health Leaders; Canadian Patient Safety Officer certification.
  Graduated from the Harvard Medical School of Clinical Scholars Research Studies.
  Appointed to the National Deprescribing Team with the Canadian Deprescribing Network.
• Donna M. Lisi: Clinical Pharmacist, LTC/PAC at Hackensack Meridian Health in Eatontown, New Jersey.

Introduction

The GI/Liver/Nutrition PRN would like to congratulate its members for their inspiring accomplishments this past year! We are continuing to explore new ways to engage our members on our social media platforms, including Twitter (@accpGILNprn) and Facebook (ACCP GI/Liver/Nutrition PRN). We would love to hear from you if you have new ideas on how our PRN can serve your professional interests!

Promotions

• Jennifer Andres: Clinical Associate Professor of Pharmacy Practice, Temple University School of Pharmacy.
• Joe Ybarra: Director of Corporate Clinical Pharmacy, CHRISTUS Health.

Awards

• Vanessa Kumpf: Stanley Serlick Award, American Society for Parenteral and Enteral Nutrition (ASPEN).

Publications

• Min AC, Andres JL, Grover AB, et al. Pharmacist comfort and awareness of HIV and HCV point of care testing in community settings. Health Promot Pract 2019 Jul 1. [Epub ahead of print]
• Qureshi K, Petersen T, Andres J. Hepatitis C treatment differences in elderly patients: single-center retrospective study. Ann Pharmacother 2020;54:113-21.
• Lampertico P, Buti M, Fung S, Ahn SH, Chuang WL, Tak WY, Ramji A, Chen CY, Tam E, Bae H, Ma X, Flaherty JF, et al. Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patients with chronic hepatitis B: a randomised, double-blind, phase 3, multicentre non-inferiority study. Lancet Gastroenterol Hepatol 2020 Feb 20. [Epub ahead of print]
• Lok AS, Zoulim F, Dusheiko G, Chan HLY, Buti M, Ghany MG, Gaggar A, Yang JC, Wu G, Flaherty JF, et al. Durability of hepatitis B surface antigen loss with nucleotide analogue and peginterferon therapy in patients with chronic hepatitis B. Hepatol Commun 2020;4:8-20.
• Marcellin P, Wong DK, Sievert W, Buggisch P, Petersen J, Flisiak R, Manns M, Kaita K, Krastev Z, Lee SS, Cathcart AL, Crans G, Op den Brouw M, Jump B, Gaggar A, Flaherty J, et al. Ten-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B virus infection. Liver Int 2019;39:1868-75.
• Gentene A, Guido M, Woolf B, et al. Multidisciplinary team utilizing pharmacists in multimodal, bundled care reduce chronic obstructive pulmonary disease hospitalization rates. J Pharm Pract 2019 Nov 26. [Epub ahead of print]
• Zafar MA, Nguyen B, Gentene A, et al. Pragmatic challenge of sustainability: long-term adherence to COPD care bundle maintains lower readmission rate. Jt Comm J Qual Patient Saf 2019;45:639-45.
• Hampson K, Nguyen T. A review of Intravenous iron replacement medications for nurse practitioners. J Nurse Pract 2020;16:224-7.
• Fasinu PS, Rapp GK. Herbal interaction with chemotherapeutic drugs – a focus on clinically significant findings. Front Oncol 2019;9:1356.
• Rife K, Lyman A, LeClerc-Kamieniecki S, et al. Significant HbA1c lowering in patients achieving a hepatitis C virus cure. Fed Pract 2019;36(suppl 2):S26-S32.
• Hall CL, Fominaya CE, Gebregziabher M, Milfred-LaForest SK, Rife KM, et al. Improving transplant medication safety through a technology and pharmacist intervention (ISTEP): protocol for a cluster randomized controlled trial. JMIR Res Protoc 2019;8:e13821.
• Brethauer SA, Grieco A, Fraker T, Evans-Labok K, Smith AN, et al. Employing Enhanced Recovery Goals in Bariatric Surgery (ENERGY): a national quality improvement project using the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP). Surg Obes Relat Dis 2019;15:77-89.
• Patel G, Hyland S, Birrer K, Wolfe R, Lovely J, Smith A, et al. Perioperative clinical pharmacy practice: responsibilities and scope within the surgical care continuum. JACCP 2020;3:501-19.

Presentations

• Clouser A, Huang E, Hampson K. Comparison of maintenance fluid provision in patients with sickle cell disease experiencing vaso-occlusive pain crisis. Presented at: ASHP Midyear Clinical Meeting; December 2019; Las Vegas, NV.
• Smith A:
  Enhanced recovery after surgery: national experience and medication protocols. Invited podium presentation at: Obesity Week; November 4, 2019; Las Vegas, NV.
  Multimodal pain management & discharge prescribing. Invited podium presentation at: Obesity Week; November 4, 2019; Las Vegas, NV.
  Pharmacotherapy in bariatric surgical patients: a clinical & research challenge. Invited podium presentation at: American College of Clinical Pharmacology Annual Meeting; September 15, 2019; Chicago, IL.
  Medical management of chronic disease post bariatric surgery. Invited podium presentation at: Obesity Weekend; June 21, 2019; Chicago, IL.

Notable Achievements

• Amy Kruger Howard: Partnered with the Institute of Human Virology Nigeria to implement a clinical trial on ART adherence for children 0–10 years of age using caregiver peer mentorship. This project was conducted with the help of a CIPHER grant.

Promotions

• Daniel Touchette: Co-Director, University of Illinois at Chicago Center for Pharmacoepidemiology and Pharmacoeconomic Research.

Awards

• Omolola Adeoye-Olatunde: Indiana CTSI TL1 Postdoctoral Trainee Kroenke Best Poster Award.
• Chris Frei: UT Austin, Faculty Mentor of the Year (inaugural), January 2020.

Grants

• Daniel Touchette: Principal Investigator, Institute for Clinical and Economic Review ($425,000).
• Erin R. Weeda: Duke Endowment – “Leveraging an Interprofessional Diabetes Telehealth Service to Optimize.”

Publications

• Coe AB, Adeoye-Olatunde OA, Pestka DL, et al. Patterns and predictors of older adult Medicare Part D beneficiaries’ receipt of medication therapy management. Res Social Adm Pharm 2019 Dec 9. [Epub ahead of print]
• McPherson KL, Adeoye-Olatunde OA, Osborne J, et al. Community pharmacists’ and residents’ decision-making and unmet information needs when completing comprehensive medication reviews. J Am Pharm Assoc 2020 Jan 24. [Epub ahead of print]
• Pestka DL, Farley JF, Zillich AJ, Coe AB, Farris KB, Adeoye-Olatunde OA, et al. Nationwide estimates of medication therapy management delivery under the Medicare Prescription Drug Benefit. J Am Pharm Assoc 2020 Jan 8. [Epub ahead of print].
• Silva Almodóvar A, Nahata MC. Potentially harmful medication use among medicare patients with heart failure. Am J Cardiovasc Drugs 2020 Feb 21. [Epub ahead of print]
• Bingham J, Silva Almodóvar A, Lee H, et al. The role of the pharmacist in mental health: an investigation of the impact of pharmacist-led interventions on psychotropic medication adherence in patients with diabetes. J Am Pharm Assoc 2020 Jan 24. [Epub ahead of print]
• Agboola F, Atlas SJ, Touchette DR, et al. The effectiveness and value of esketamine for the management of treatment-resistant depression. J Manag Care Spec Pharm 2020;26:16-20.
• Carlson JJ, Walton SM, Basu A, Chapman RH, Campbell JD, McQueen RB, Pearson SD, Touchette DR, et al. Achieving appropriate model transparency: challenges and potential solutions for making value-based decisions in the United States. Pharmacoeconomics 2019;37:1321-7.
• Caskey R, Moran K, Touchette D, et al. Effect of comprehensive care coordination on Medicaid expenditures compared with usual care among children and youth with chronic disease: a randomized trial. JAMA Netw Open 2019;2:e1912604.
• Gor D, Gerber BS, Walton SM, Lee TA, Nutescu EA, Touchette DR. Antidiabetic drug use trends in patients with type 2 diabetes mellitus and chronic kidney disease: a cross-sectional analysis of the National Health and Nutrition Examination Survey. J Diabetes 2019 Oct 25. [Epub ahead of print]
• Gor D, Lee TA, Schumock GT, Walton SM, Gerber BS, Nutescu EA, Touchette DR. Adherence and persistence with DPP-4 inhibitors versus pioglitazone in type 2 diabetes patients with chronic kidney disease: a retrospective claims database analysis. J Manag Care Spec Pharm 2020;26:67-75.
• Kim K, Touchette DR, Cavallari LH, et al. Cost-effectiveness of strategies to personalize the selection of P2Y(12) inhibitors in patients with acute coronary syndrome. Cardiovasc Drugs Ther 2019;33:533-46.
• Rodriguez R, Touchette DR. Part II: statistics in practice: statistics overview. J Am Coll Clin Pharm 2019;3:554-9.
• Talon B, Perez A, Yan C, Alobaidi A, Zhang KH, Schultz BG, Suda KJ, Touchette DR. Economic evaluations of clinical pharmacy services in the United States: 2011-2017. J Am Coll Clin Pharm 2019 Dec 10. [Epub ahead of print]
• Weeda ER, Nguyen E, Martin S, et al. The impact of non-medical switching among ambulatory patients: an updated systematic literature review. J Mark Access Health Policy 2019;7:1678563.
• Weeda ER, Su Z, Taber DJ, et al. Costs and factors associated with heart failure following kidney transplantation – a single-center retrospective cohort study. Transpl Int 2020 Jan 13. [Epub ahead of print]
• Halavonich L, Robert S, McGraw D, Weeda E, et al. Management of delirium at an academic medical center: plans for antipsychotic prescribing upon discharge. Ment Health Clin 2020;10:25-9.
• Prentice A, Ruiz I, Weeda ER. Medication adherence to rivaroxaban and dabigatran in patients with non-valvular atrial fibrillation: a meta-analysis. J Thromb Thrombolysis 2019 Nov 5. [Epub ahead of print]

Awards

• Farah Raheem: 2020 Top 10 Trainee Research, Hematology/Oncology Pharmacy Association.
• Amanda Seddon: New Practitioner Award, American Society for Transplantation and Cellular Therapy, Pharmacy Special Interest Group.

Grants

• Ashley Glode: University of Colorado Cancer Center Investigator-Initiated Trial – $50,000.
• Shanada Monestime: NHLBI Small Research Grant through Obesity Health Disparities PRIDE – $10,800.

Publications

• Han F, Dellacecca ER, Barse LW, Cosgrove C, Henning SW, Ankney CM, et al. Adoptive T cell transfer to treat lymphangioleiomyomatosis. Am J Respir Cell Mol Biol 2020 Feb 20. [Epub ahead of print]
• Hallin J, Engstrom LD, Hargis L, Calinisan A, Aranda R, et al. The KRASG12C inhibitor MRTX849 provides insight toward therapeutic susceptibility of KRAS-mutant cancers in mouse models and patients. Cancer Discov 2020;10:54-71.
• Arnall JR, Moore DC, Hill HL, et al. Enhancing the feasibility of outpatient daratumumab administration via a split-dosing strategy with initial doses. Leuk Lymphoma 2019;60:2295-8.
• Hartsell L, Janes A, Larck C, Park S, Arnall JR. Ibrutinib for the treatment of Bing-Neel syndrome, a complication of Waldenström macroglobulinemia: patient case report. J Oncol Pharm Pract 2019;25:1534-9.
• Hill H, Arnall J, Janes A, et al. A review of R-DHAP administration in the outpatient setting and a case of the alternative regimen R-DHAX given outpatient for refractory diffuse large B-cell lymphoma. J Oncol Pharm Pract 2019;25:2041-4.
• Kupsh A, Arnall J, Voorhees P. A successful case of venetoclax-based therapy in relapsed/refractory secondary plasma cell leukemia. J Oncol Pharm Pract 2019 Dec 22. [Epub ahead of print]
• Patel JN, Hamadeh IS, Robinson M, Shahid Z, Symanowski J, Steuerwald N, Hamilton A, Reese ES, Plesca DC, Arnall J, et al. Evaluation of CYP2C19 genotype-guided voriconazole prophylaxis after allogeneic hematopoietic cell transplant. Clin Pharmacol Ther 2020;107:571-9.
• Pillinger KE, McClanahan S, Arnall J, et al. Expanding beyond vancomycin and aminoglycosides: a novel foscarnet pharmacist-managed dosing service. Ann Pharmacother 2019;53:1069-70.
• Tran T, Arnall J, Moore DC, et al. Vonicog alfa for the management of von Willebrand disease: a comprehensive review and single-center experience. J Thromb Thrombolysis 2020 Jan 4. [Epub ahead of print]
• Zhao JC, Arnall JR, Martin AL, et al. A review of growth factor support in bloodless autologous hematopoietic stem cell transplant. Biol Blood Marrow Transplant 2019;25:e305-9.
• Zhao JC, Arnall JR, Martin AL, et al. Letter to the editor concerning “Single-institution experience of performing bloodless transplant in Jehovah’s Witness patients” by Coltoff A, Aditya S, Solmaz A, Steinberg A. (Hematol Oncol Stem Cell Ther 2019;12:44-9). Hematol Oncol Stem Cell Ther 2019 Oct 11. [Epub ahead of print]
• Freeman EE, Busakhala N, Regan S, Asirwa FC, et al. Real-world use of chemotherapy for Kaposi’s sarcoma in a large community-based HIV primary care system in Kenya. BMC Cancer 2020;20:71.
• Banks C, Hughes K, Simpkins C, et al. Osteoarthritis in older adults: nonsteroidal anti-inflammatory drugs versus opioids. Sr Care Pharm 2019;34:674-7.
• Kuhn AK, Bartoo GT, Dierkhising RA, et al. Iron deficiency anemia associated with extracorporeal photopheresis: a retrospective analysis. J Clin Apher 2019;34:666-71.
• Potter A, Beck B, Ngorsuraches S. Tbo-filgrastim versus filgrastim for stem cell mobilization and engraftment in autologous hematopoietic stem cell transplant patients: a retrospective review. J Oncol Pharm Pract 2020;26:23-8.
• Benjamin T, Schumacher C. Sodium–glucose cotransporter-2 inhibitors and urinary tract infections. Ann Intern Med 2019;171:944.
• Stuckert AJ, Schafer ES, Bernhardt MB, et al. Use of allopurinol to reduce hepatotoxicity from 6-mercaptopurine (6-MP) in patients with acute lymphoblastic leukemia (ALL). Leuk Lymphoma 2019 Dec 16. [Epub ahead of print]
• Joseph M, Brady R, Attridge R, et al. Critically ill recipients of weight-based fluconazole meeting Drug-Induced Liver Injury Network criteria. Hosp Pharm 2019;54:378-84.
• Al-Jammali Z, Beckner B, Bubalo J. Ibrutinib-related atrial fibrillation: an anticoagulant challenge. J Hematol Oncol Pharm 2019;9:47-50.
• Dixon BN, Daley RJ, Buie LW, et al. Correlation of IL-6 secretion and hyponatremia with the use of CD19+ chimeric antigen receptor T-cells. Clin Nephrol 2020;93:42-6.
• Offin M, Guo R, Wu SL, Sabari JD, Land JD, Ni A, Montecalvo J, Halpenny DF, Buie LW, et al. Immunophenotype and response to immunotherapy of RET-rearranged lung cancers. JCO Precis Oncol 2019;3:1-8.
• Cordes LM, Davarpanah NN, Reoma LB, et al. Neurotoxicities associated with checkpoint inhibitors: two case reports and a review of the literature. Clin Case Rep 2019;8:24-32.
• Collins JM, Donahue RN, Tsai YT, Manu M, Palena C, Gatti-Mays ME, Marté JL, Madan RA, Karzai F, Heery CR, Strauss J, Abdul-Sater H, Cordes L, et al. Phase I trial of a modified vaccinia Ankara priming vaccine followed by a fowlpox virus boosting vaccine modified to express brachyury and costimulatory molecules in advanced solid tumors. Oncologist 2019 Dec 26. [Epub ahead of print]
• Del Rivero J, Cordes LM, Klubo-Gwiezdzinska J, et al. Endocrine-related adverse events related to immune checkpoint inhibitors: Proposed algorithms for management. Oncologist 2019 Oct 10. [Epub ahead of print]
• Gatti-Mays ME, Redman JM, Donahue RN, Palena C, Madan RA, Karzai F, Bilusic M, Sater HA, Marté JL, Cordes LM, et al. A phase I trial using a multitargeted recombinant adenovirus 5 (CEA/MUC1/Brachyury)-based immunotherapy vaccine regimen in patients with advanced cancer. Oncologist 2019 Oct 8. [Epub ahead of print]
• Redman JM, Rhea LP, Brofferio A, Whelpley M, Gulley JL, Gatti-Mays ME, McMahon S, Cordes LM, et al. Successful 5-fluorouracil (5-FU) infusion re-challenge in a metastatic colorectal cancer patient with coronary artery disease who experienced symptoms consistent with coronary vasospasm during first 5-FU infusion. J Gastrointest Oncol 2019;10:1010-4.
• Asquith CRM, Maffuid KA, Laitinen T, Torrice CD, Tizzard GJ, Crona DJ, et al. Targeting an EGFR water network with 4-anilinoquin(az)oline inhibitors for chordoma. ChemMedChem 2019;14:1693-700.
• Zhu J, Patel T, Miller JA, Torrice CD, Aggarwal M, Sketch MR, Alexander MD, Armistead PM, Coghill JM, Grgic T, Jamieson KJ, Ptachcinski JR, Riches ML, Serody JS, Schmitz JL, Shaw JR, Shea TC, Suzuki O, Vincent BG, Wood WA, Rao KV, Wiltshire T, Weimer ET, Crona DJ. Influence of germline genetics on tacrolimus pharmacokinetics and pharmacodynamics in allogeneic hematopoietic stem cell transplant patients. Int J Mol Sci 2020;21:858.
• Davis LE, Nicholls LA, Babiker HM, et al. PD-1 inhibition achieves a complete metabolic response in a patient with malignant peripheral nerve sheath tumor. Cancer Immunol Res 2019;7:1396-400.
• Dixon DN, Daley RJ, Buie LW, et al. Correlation of IL-6 secretion and hyponatremia with the use of CD19+ chimeric antigen receptor T-cells. Clin Nephrol 2020;93:42-6.
• Beuge MJ, Kumar A, Dixon BN, et al. Management of mantle cell lymphoma in the era of novel oral agents. Ann Pharmacother 2020 Feb 20. [Epub ahead of print]
• Kristin SM, Dixon BN, Ni A, et al. Incidence of infectious complications with the combination of bendamustine and an anti-CD20 monoclonal antibody. Leuk Lymphoma 2020;61:364-9.
• Duco MR, Murdock JL, Reeves DJ. Trastuzumab/hyaluronidase-oysk: a new option for patients with HER2-positive breast cancer. Ann Pharmacother 2020;54:254-61.
• Wang E, Jan AS, Doan VP, Ferguson JB, et al. Leflunomide therapy for refractory cytomegalovirus infections in hematopoietic stem cell transplant recipients. J Oncol Pharm Pract 2019;25:1731-7.
• Alewine C, Ahmad M, Peer CJ, Hu ZI, Lee MJ, Yuno A, Kindrick JD, Thomas A, Steinberg SM, Trepel JB, Figg WD, et al. Phase I/II study of the mesothelin-targeted immunotoxin LMB-100 with nab-paclitaxel for patients with advanced pancreatic adenocarcinoma. Clin Cancer Res 2020;26:828-36.
• Barbier RH, Chau CH, Figg WD. Androgen receptor splice variant 7 (AR-V7) and AR full-length (AR-FL) as predictive biomarkers of therapeutic resistance: partners in crime? BJU Int 2019;124:549-50.
• Elechalawar CK, Hossen MN, Shankarappa P, Peer CJ, Figg WD, et al. Targeting pancreatic cancer cells and stellate cells using designer nanotherapeutics in vitro. Int J Nanomed 2020;15:991-1003.
• Hawley JE, Pan S, Figg WD, et al. Association between immunosuppressive cytokines and PSA progression in biochemically recurrent prostate cancer treated with intermittent hormonal therapy. Prostate 2020;80:336-44.
• Hicks KC, Knudson KM, Lee KL, Hamilton DH, Hodge JW, Figg WD, et al. Cooperative immune-mediated mechanisms of the HDAC inhibitor entinostat, an IL15 superagonist, and a cancer vaccine effectively synergize as a novel cancer therapy. Clin Cancer Res 2020;26:704-16.
• Huang PA, Beedie SL, Chau CH, Venzon DJ, Gere S, Kazandjian D, Korde N, Mailankody S, Landgren O, Figg WD. Cereblon gene variants and clinical outcome in multiple myeloma patients treated with lenalidomide. Sci Rep 2019;9:14884.
• Knechel MA, Schmidt KT, Figg WD. Combination treatment in metastatic castration-resistant prostate cancer: can we safely boost efficacy by adding radium-223? Cancer Biol Ther 2020;21:1-3.
• Rodgers LT, Lester McCully CM, Odabas A, Cruz R, Peer CJ, Figg WD, et al. Characterizing the pharmacokinetics of panobinostat in a non-human primate model for the treatment of diffuse intrinsic pontine glioma. Cancer Chemother Pharmacol 2020 Jan 1. [Epub ahead of print]
• Schmidt KT, Peer CJ, Huitema ADR, Williams MD, Wroblewski S, Schellens JHM, Madan RA, Figg WD. Measurement of NLG207 (formerly CRLX101) nanoparticle-bound and released camptothecin in human plasma. J Pharm Biomed Anal 2020;181:113073.
• Sissung TM, Barbier RH, Price DK, Plona TM, Pike KM, Mellott SD, Baugher RN, Whiteley GR, Soppet DR, Venzon D, Berman A, Rajan A, Giaccone G, Meltzer P, Figg WD. Comparison of eight technologies to determine genotype at the UGT1A1 (TA)n repeat polymorphism: potential clinical consequences of genotyping errors? Int J Mol Sci 2020;21:pii:E896.
• Sissung TM, Figg WD. Stem cell clinics: risk of proliferation. Lancet Oncol 2020;21:205-6.
• Strope JD, Peer CJ, Sissung TM, Hall OM, Huang PA, Harris EM, Gustafson KR, Henrich CJ, Sigano DM, Pauly GT, Schneider JP, Bates SE, Figg WD. Botryllamide G is an ABCG2 inhibitor that improves lapatinib delivery in mouse brain. Cancer Biol Ther 2020;21:223-30.
• Subramaniyan B, Rajaputra P, Nguyen L, Li M, Peer CJ, Kindrick J, Figg WD, et al. Local and systemic antitumor effects of photo-activatable paclitaxel prodrug on rat breast tumor models. Photochem Photobiol 2019 Dec 28. [Epub ahead of print]
• Dashputre A, Gatwood KS, Schmidt J, et al. Medication adherence, healthcare utilization and costs among patients initiating oral oncolytics for multiple myeloma or chronic lymphocytic leukemia/small lymphocytic lymphoma. J Managed Care Spec Pharm 2020;26:186-96.
• Patel DA, Dhedin N, Chen H, Karnik L, Gatwood KS, et al. Early viral reactivation despite excellent immune reconstitution following haploidentical bone marrow transplant with post-transplant Cytoxan for sickle cell disease. Transplant Infect Dis 2019 Nov 29. [Epub ahead of print]
• Dashputre A, Gatwood KS, Schmidt J, et al. Impact of oral oncolytic initiation on medication adherence for pre-existing comorbid chronic conditions. J Oncol Pharm Pract 2019 Oct 1. [Epub ahead of print]
• Glode AE, Davis SL, Jain SK, et al. Quality improvement project to standardize a prehabilitation pathway for patients with esophageal cancer receiving neoadjuvant chemoradiation. J Clin Pathways 2019;5:40-4.
• Cannon L, Academia EC, Glode AE. A review of PI3K inhibitors in B-cell malignancies. J Adv Pract Oncol 2019;10:717-25.
• Laird CM, Glode AE, Schwarz K, Lam ET, O’Bryant CL. Evaluation of fosaprepitant-associated hypersensitivity reactions at the University of Colorado Outpatient Cancer Center. J Oncol Pharm Pract 2020 Jan 19. [Epub ahead of print]
• Pittman WL, Wern C, Glode AE. A review of biosimilars and their potential use in oncology treatment and supportive care in the United States. J Hematol Oncol Pharm 2019;9:133-41.
• Weiss J, Glode A, Messersmith WA, et al. Sacituzumab govitecan: breakthrough targeted therapy for triple-negative breast cancer. Expert Rev Anticancer Ther 2019;19:673-9.
• Vermeulen LC, Swarthout MD, Alexander GC, Ginsburg DB, Pritchett KO, White SJ, Tryon J, Emmerich C, Nesbit TW, Greene W, et al. ASHP Foundation pharmacy forecast 2020: strategic planning advice for pharmacy departments in hospitals and health systems. Am J Health Syst Pharm 2020;77:84-112.
• Smith DV, Gautreaux S, Gulbis AM, et al. Program development of a preceptor bootcamp for operational pharmacy preceptors. Am J Health Syst Pharm 2020;77(suppl 1):S2-S7.
• Haidar CE, Relling MV, Hoffman JM. Preemptively precise: returning and updating pharmacogenetic test results to realize the benefits of preemptive testing. Clin Pharmacol Ther 2019;106:942-4.
• Caudle KE, Sangkuhl K, Whirl-Carrillo M, Swen JJ, Haidar CE, et al. Standardizing CYP2D6 genotype to phenotype translation: consensus recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group. Clin Transl Sci 2020;13:116-24.
• Hoshitsuki K, Crews KR, Yang W, Smith CA, Hankins JS, Turner AJ, Broeckel U, McMillin GA, Relling MV, Haidar CE. Challenges in clinical implementation of CYP2D6 genotyping: choice of variants to test affects phenotype determination. Genet Med 2020;22:232-3.
• Patel JN, Boselli D, Hamadeh IS, et al. Pain management using clinical pharmacy assessments with and without pharmacogenomics in an oncology palliative medicine clinic. JCO Oncol Pract 2020;16:e166-e174.
• Patel JN, Hamadeh IS, Robinson M, et al. Evaluation of CYP2C19 genotype-guided voriconazole prophylaxis after allogeneic hematopoietic cell transplant. Clin Pharmacol Ther 2020;107:571-9.
• Harvey RD, Ratain MJ. A cost-focused alternative cancer medication dispensing strategy – “pack splitting.” JAMA Oncol 2019 Oct 17. [Epub ahead of print]
• Appleman LJ, Beumer JH, Jiang Y, Lin Y, Ding F, Puhalla S, Swartz L, Owonikoko TK, Harvey RD, et al. Phase 1 study of veliparib (ABT-888), a poly (ADP-ribose) polymerase inhibitor, with carboplatin and paclitaxel in advanced solid malignancies. Cancer Chemother Pharmacol 2019;84:1289-301.
• Balogh EP, Bindman AB, Eckhardt SG, Halabi S, Harvey RD, et al. Challenges and opportunities to updating prescribing information for longstanding oncology drugs. Oncologist 2019 Dec 4. [Epub ahead of print]
• Bilen MA, Martini DJ, Liu Y, Shabto JM, Brown JT, Williams M, Khan AI, Speak A, Lewis C, Collins H, Kissick HT, Carthon BC, Akce M, Shaib WL, Alese OB, Pillai RN, Steuer CE, Wu CS, Lawson DH, Kudchadkar RR, El-Rayes BF, Ramalingam SS, Owonikoko TK, Harvey RD, et al. Combined effect of sarcopenia and systemic inflammation on survival in patients with advanced stage cancer treated with immunotherapy. Oncologist 2019 Dec 5. [Epub ahead of print]
• Hall KH, Liu Y, Jiang C, Harvey RD. New and worsening long-term immune-related adverse events with PD-1/PD-L1 pathway agents in patients with cancer. Pharmacotherapy 2020;40:133-41.
• Markham MJ, Wachter K, Agarwal N, Bertagnolli MM, Chang SM, Dale W, Diefenbach CSM, Rodriguez-Galindo C, George DJ, Gilligan TD, Harvey RD, et al. Clinical Cancer Advances 2020: annual report on progress against cancer from the American Society of Clinical Oncology. J Clin Oncol 2020 Feb 4. [Epub ahead of print]
• Martini DJ, Kline MR, Liu Y, Shabto JM, Williams MA, Khan AI, Lewis C, Collins H, Akce M, Kissick HT, Carthon BC, Shaib WL, Alese OB, Pillai RN, Steuer CE, Wu CS, Lawson DH, Kudchadkar RR, El-Rayes BF, Ramalingam SS, Owonikoko TK, Harvey RD, et al. Adiposity may predict survival in patients with advanced stage cancer treated with immunotherapy in phase 1 clinical trials. Cancer 2020;126:575-82.
• Medina P, Jeffers KD, Trinh VA, Harvey RD. The role of pharmacists in managing adverse events related to immune checkpoint inhibitor therapy. J Pharm Pract 2019 Nov 6. [Epub ahead of print]
• Owonikoko TK, Harvey RD, Carthon B, et al. A phase I study of safety, pharmacokinetics, and pharmacodynamics of concurrent everolimus and buparlisib treatment in advanced solid tumors. Clin Cancer Res 2020 Jan 31. [Epub ahead of print]
• Vishwanathan K, Cantarini M, So K, Masson E, Fetterolf J, Ramalingam SS, Harvey RD. Impact of disease and treatment response in drug-drug interaction studies: osimertinib and simvastatin in advanced non-small cell lung cancer. Clin Transl Sci 2020;13:41-6.
• Murphy M, Martin G, Mahmoudjafari Z, Bivona C, Grauer D, Henry D. Intraperitoneal paclitaxel and cisplatin compared with dose-dense paclitaxel and carboplatin for patients with stage III ovarian cancer. J Oncol Pharm Pract 2020 Jan 16. [Epub ahead of print]
• Shillingburg A, Michaud LB, Schwartz R, Anderson J, Henry DW. Women in oncology pharmacy leadership: a white paper. J Oncol Pharm Pract 2020;26:175-86.
• Hickey E, Clemons B, Griffin S, et al. Multicenter evaluation of arsenic trioxide dosing in obese patients with low-intermediate risk acute promyelocytic leukemia. Leuk Lymphoma 2019;60:3557-60.
• Hicks JK, Bishop JR, Gammal RS, et al. A call for clear and consistent communications regarding the role of pharmacogenetics in antidepressant pharmacotherapy. Clin Pharmacol Ther 2020;107:50-2.
• Hicks JK, Quilitz RE, Komrokji RS, et al. Prospective CYP2C19-guided voriconazole prophylaxis in patients with neutropenic acute myeloid leukemia reduces the incidence of subtherapeutic antifungal plasma concentrations. Clin Pharmacol Ther 2020;107:563-70.
• Cavallari LH, Van Driest SL, Prows CA, Bishop JR, Limdi NA, Pratt VM, Ramsey LB, Smith DM, Tuteja S, Duong BQ, Hicks JK, et al. Multi-site investigation of strategies for the clinical implementation of CYP2D6 genotyping to guide drug prescribing. Genet Med 2019;21:2255-63.
• Hockings JK, Pasternak AL, Erwin AL, Mason NT, Eng C, Hicks JK. Pharmacogenomics: an evolving clinical tool for precision medicine. Cleve Clin J Med 2020;87:91-9.
• Huddart R, Hicks JK, Ramsey LB, et al. PharmGKB summary: sertraline pathway, pharmacokinetics. Pharmacogenet Genomics 2020;30:26-33.
• LeClair JN, Chamberlin KW, Clemet J, Holle LM. Documentation of medical marijuana use in cancer patients. J Oncol Pharm Pract 2019 Nov 10. [Epub ahead of print]
• Puri S, Holle LM, Forouhar FA, et al. Subcutaneous metastasis from recurrent basaloid squamous cell carcinoma of the esophagus. J Oncol Pharm Pract 2019;25:492-6.
• Segal EM, Bates J, Flezsar SL, Holle LM, et al. Demonstrating the value of the oncology pharmacist within the healthcare team. J Oncol Pharm Pract 2019;25:1945-67.
• Holtan S, DeFor TE, Rashidi A, Khoruts A, Staley C, Turcotte LM, Jacobson PA, et al. Pre-transplant serum claudin-3 predicts intestinal graft-versus-host disease and non-relapse mortality risk after allogeneic hematopoietic cell transplantation. Blood 2019;134(suppl 1):39.
• Holtan S, Hoeschen A, Cao Q, Arora M, Bachanova V, Brunstein CG, Miller JS, Rashidi A, Slungaard A, Ustun C, Vercellotti GM, Warlick ED, Betts BC, El Jurdi N, He F, Chen C, Gandhi I, Wagner JE, Blazar BR, Jacobson P, et al. Facilitating resolution of life-threatening acute graft-vs-host disease with human chorionic gonadotropin and epidermal growth factor. Biol Blood Marrow Transplant 2019;25:S240-1.
• Johnson SG, Jacobson P, Wolf SM, et al. Generalizable architectures and principles of informatics for scalable personalized and precision medicine (PPM) decision support. In: Adam T, Aliferis C, eds. Personalized and Precision Medicine Informatics. Health Informatics. Cham, Switzerland: Springer, 2020:277-303.
• Moscoso CG, Potz KR, Shaoyuan T, Jacobson PA, et al. Precision medicine, agriculture, and genome editing: science and ethics. Ann NY Acad Sci 2019 Nov 13. [Epub ahead of print]
• Rivers, Z, Stenehjem DD, Jacobson P, et al. A cost-effectiveness analysis of pretreatment DPYD and UGT1A1 screening in patients with metastatic colorectal cancer (mCRC) treated with FOLFIRI + bevacizumab (FOLFIRI+Bev). J Clin Oncol 2020;38:168.
• La-Beck NM, Liu X, Shmeeda H, et al. Repurposing amino-bisphosphonates by liposome formulation for a new role in cancer treatment. Semin Cancer Biol 2019 Dec 23. [Epub ahead of print]
• La-Beck NM, Nguyen DT, Le AD, et al. Optimizing patient outcomes with PD-1/PD-L1 immune checkpoint inhibitors for the first-line treatment of advanced non-small cell lung cancer. Pharmacotherapy 2020;40:239-55.
• Lam SY, Lee CS, Sharma S, et al. Bevacizumab-induced dysphonia: a case report with brief review of literature. J Oncol Pharm Pract 2019 Nov 26. [Epub ahead of print]
• Monson T, Greer D, Kreikemeier E, Liewer S. Olanzapine as a rescue antiemetic in hematopoietic stem cell transplant. J Oncol Pharm Pract 2019 Oct 21. [Epub ahead of print]
• Signorelli J, Zimmer A, Liewer S, et al. Incidence of febrile neutropenia in autologous hematopoietic stem cell transplant (HSCT) recipients on levofloxacin prophylaxis. Transpl Infect Dis 2019;e13225.
• Pearce J, Peters M, May N, Marshall H, et al. Care of the patient with invasive meningococcal disease by prehospital emergency medical service clinicians: a scoping review. BMJ Open 2020;10:e033447.
• McCune JS, Quinones CM, Ritchie J, et al. Harmonization of busulfan plasma exposure unit (BPEU): a community-initiated consensus statement. Biol Blood Marrow Transplant 2019;25:1890-7.
• Cox EJ, Maharao N, Patilea-Vrana G, Unadkat JD, Rettie AE, McCune JS, et al. A marijuana-drug interaction primer: precipitants, pharmacology, and pharmacokinetics. Pharmacol Ther 2019;201:25-38
• Krakow EF, Gyurkocza B, Storer BE, Chauncey TR, McCune JS, et al. Phase I/II multisite trial of optimally dosed clofarabine and low-dose TBI for hematopoietic cell transplantation in acute myeloid leukemia. Am J Hematol 2020;95:48-56.
• Natarajan R, Aljaber D, Au D, Thai C, Sanchez A, Nunez A, Resto C, Chavez T, Jankowska MM, Benmarhnia T, Yang JA, Jones V, Tomsic J, McCune JS, et al. Environmental exposures during puberty: window of breast cancer risk and epigenetic damage. Int J Environ Res Public Health 2020;17:pii: E493.
• Hayne J, Kubusek K, Tosh PK, Bennani NN, Lin Y, Ansell S, Bisneto JV, Nedved A, et al. Infectious complications of CAR T-cell therapy in non-Hodgkin lymphoma. Biol Blood Marrow Transplant 2020;26(suppl):S275.
• Kubusek J, Hayne J, Lin Y, Nedved A, et al. Hematologic toxicities of CAR T-cell therapy in non-Hodgkin lymphoma. Biol Blood Marrow Transplant 2020;26(suppl):S264.
• Novo M, Sidiqi MH, Paludo J, Gandhi S, Kubusek J, Truong T, Hayne J, Ansell SM, Bennani NN, Villasboas JC, Nedved A, et al. Peak lymphocyte count after CAR T infusion is a clinically accessible test that correlates with clinical response in axicabtagene ciloleucel therapy for lymphoma. Blood 2019;134(suppl 1):4106.
• Burnett-Hartman AN, Udaltsova N, Kushi LH, Neslund-Dudas C, Rahm AK, Pawloski PA, et al. Clinical molecular marker testing data capture to promote precision medicine research within the Cancer Research Network. JCO Clin Cancer Inform 2019;3:1-10.
• Kent DJ, McMahill-Walraven CN, Panozzo CA, Pawloski PA, et al. Descriptive analysis of long- and intermediate-acting insulin and key safety outcomes in adults with type 2 diabetes mellitus. J Manag Care Spec Pharm 2019;25:1162-71.
• Lee C, Check DK, Brenman LM, Kushi LH, Epstein MM, Neslund-Dudas C, Pawloski PA, et al. Adjuvant endocrine therapy for breast cancer patients; impact of a health system outreach program to improve adherence. Breast Cancer Res Treat 2020;180:219-26.
• Margolis KL, Crain AL, Bergdall AR, Beran M, Anderson JP, Solberg LI, O’Connor PJ, Spril-Hillen JM, Pawloski PA, et al. Design of a pragmatic cluster-randomized trial comparing telehealth care and best practice clinic-based care for uncontrolled high blood pressure. Contemp Clin Trials 2020 Jan 22. [Epub ahead of print]
• McMahill-Walraven CN, Kent DJ, Panozzo CA, Pawloski PA, et al. Harnessing the Biologics and Biosimilars Collective Intelligence Consortium to evaluate patterns of care. J Manag Care Spec Pharm 2019;25:1156-61.
• Peterson RA, Kashyap B, Pawloski PA, et al. Unique case report of a meningeal sarcoma arising during ongoing treatment for progressing intraparenchymal glioma: case report. Oncol Med 2019;2019:7950782.
• Lin A, Maloy M, Su Y, Bhatt V, DeRespiris L, Griffin M, Lau C, Proli A, et al. Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: real-world experience. Transpl Infect Dis 2019;21:e13187.
• Maples KT, Maloy M, Devlin S, Lin A, DeRespiris L, Griffin M, Lau C, Proli AJ, et al. Lack of a significant pharmacokinetic interaction between letermovir and calcineurin inhibitors in allogeneic HCT recipients. Bone Marrow Transplant 2020 Jan 14. [Epub ahead of print]
• Przybylski DJ, Dow-Hillgartner EN, Reed MP, et al. Current state assessment survey of challenges of pharmacogenomics within oncology pharmacy practice. J Oncol Pharm Pract 2020 Jan 14. [Epub ahead of print]
• Raheem F, Kim P, Grove M, et al. Precision genomic practice in oncology: pharmacist role and experience in an ambulatory care clinic. Pharmacy 2020;8:32.
• Rayner P. Role of initiating supportive care preceding veno-occlusive disease diagnosis following allogeneic hematopoietic stem cell transplantation in children. J Pediatr Hematol Oncol 2019;41:e395-e401.
• Tossey JC, Reardon J, VanDeusen JB, et al. Comparison of conventional versus liposomal irinotecan in combination with fluorouracil for advanced pancreatic cancer: a single-institution experience. Med Oncol 2019;36:87.
• De Angelis C, Nagi C, Hoyt CC, Liu L, Roman K, Wang C, Zheng Y, Veeraraghavan J, Sethunath V, Nuciforo P, Wang T, Tsimelzon A, Mao S, Hilsenbeck SG, Trivedi MV, et al. Evaluation of the predictive role of tumor immune infiltrate in patients with HER2-positive breast cancer treated with neoadjuvant anti-HER2 therapy without chemotherapy. Clin Cancer Res 2020;26:738-45.

Other Notable Achievements

• Larry Buie: Incoming President of the Hematology/Oncology Pharmacy Association.
• Kaitlin (Katie) Rascon: ACCP Report, November 2019 Member Spotlight.

Since the HIV PRN’s first year, membership has grown from 41 members to more than 200 members. As life expectancy increases for people living with HIV, managing comorbid disease states and polypharmacy is increasingly vital. As such, the PRN will continue collaborating with other PRNs to increase networking and educational efforts for pharmacists who may interact with this population through research, education, or practice. In addition, the PRN is further integrating students and trainees because members understand the importance of guiding the next generation of pharmacists with an interest in HIV. As the field of HIV continues to evolve, there is a continuous need for collaboration and research that demonstrates the benefits and best practices for clinical pharmacists in preventing and treating HIV. The PRN’s future is vital to the continued sharing of evidence-based recommendations and experiences to optimize patient care by pharmacists around the world.

Promotions

• Agnes Cha: Clinical Pharmacy Ambulatory Care Manager, Northwell Health.
• Jacob Peace: Intern, Johns Hopkins Pharmacy Internship Program at Bartlett Clinic Outpatient Pharmacy.

Awards

• Melissa Badowski: Distinguished Service Award, ACCP HIV PRN.
• Milena Murray: Shining Star Award, Illinois Council of Health-System Pharmacists.

Publications

• Cottrell ML, Prince HMA, Schauer AP, Sykes C, Maffuid K, Poliseno A, Chun TW, Huiting E, Stanczyk FZ, Peery AF, Dellon ES, Adams JL, Gay C, Kashuba ADM. Decreased tenofovir diphosphate concentrations in a transgender female cohort: implications for HIV pre-exposure prophylaxis (PrEP). Clin Infect Dis 2019;69:2201-4.
• Blevins SR, Hester EK, Chastain DB, Cluck DB. Doravirine: a return of NNRTI class? Ann Pharmacother 2020;54:64-74.
• Brizzi M, Burgos R, Chiampas T, Michienzi S, Smith R, Yanful P, Badowski M. Impact of pharmacist-driven antiretroviral stewardship and transitions of care interventions on persons with HIV. Open Forum Infect Dis. [In press]
• Brizzi MB, Chiampas TD, Michienzi SM, Young JD, Patel MC, Badowski ME. Real-world evaluation of the safety and tolerability of abacavir/dolutegravir/lamivudine in an incarcerated population. Int J STD AIDS 2019;30:1163-8.
• Brizzi MB, Novak R, Chiampas TD. Simplification of ART in a patient living with multidrug resistant HIV-1: a case report using twice daily cobicistat and darunavir. Int J STD AIDS 2019;30:1333-6.
• Brotherton AL, Rab S, Kandiah S, et al. The impact of an automated antibiotic stewardship intervention for the management of Staphylococcus aureus bacteremia utilizing the electronic health record. J Antimicrob Chemother 2020;75:1054-60.
• Farmakiotis D, Weiss Z, Brotherton AL, et al. Successful kidney transplantation in a recipient coinfected with hepatitis C genotype 2 and HIV from a donor infected with hepatitis C genotype 1 in the direct-acting antiviral era. Case Rep Hepatol 2020;2020:7679147.
• Chastain D, Badowski M, Huesgen E, Pandit NS, Pallotta A, Michienzi S. Optimizing antiretroviral therapy in treatment-experienced patients living with HIV: a critical review of switch and simplification strategies. An opinion of the HIV Practice and Research Network of the American College of Clinical Pharmacy. J Int Assoc Provid AIDS Care 2019;18:2325958219867325.
• Biagi MJ, Schriever CA, Chiampas TD, Michienzi SM, Patel MC, Young JD, Badowski ME. Development of gynecomastia following initiation of bictegravir/emtricitabine/tenofovir alafenamide. Int J STD AIDS 2020;31:380-2.
• Hester EK, Caulder C, Penzak SR. Impact of team-based care on appropriate statin therapy prescribing in HIV-infected patients. J Am Coll Clin Pharm 2020 Jan 17. [Epub ahead of print]
• Bunn HT, Hester EK, Maldonaldo RA, et al. Evaluation of human immunodeficiency virus medication errors in a community hospital following the implementation of a pharmacist-led antiretroviral stewardship program. J Am Coll Clin Pharm 2019 Dec 5. [Epub ahead of print]
• Britt RS, LaSalvia MT, Padival S, Patel P, McCoy C, Mahoney MV. Evaluation of inpatient antimicrobial regimens for readmitted outpatient parenteral antimicrobial therapy (OPAT) patients receiving daptomycin or ertapenem for ease of administration. Open Forum Infect Dis 2019;6:ofz496.
• Burgos RM, Michienzi SM. HIV infection. In: Schwinghammer TL, Koehler JM, Borchert JS, et al, eds. Pharmacotherapy Casebook and Care Plans, 11th ed. [In press]
• Michienzi SM, Badowski ME, Brizzi M, Burgos RM, Chiamapas TD, Smith RO. Infections in immunocompromised patients. PharmacotherapyFirst 2019.
• Michienzi SM, Ladak AF, Pérez SE, Chastain DB. Antiretroviral stewardship: a review of published outcomes with recommendations for program implementation. J Int Assoc Provid AIDS Care 2020;19:2325958219898457.
• Pandit NS, Chastain DB, Pallotta AM, Badowski ME, Huesgen EC, Michienzi SM. Simplifying ARV therapy in the setting of resistance. Curr Infect Dis Rep 2019;21:38.
• Quinn KG, Christenson E, Sawkin MT. et al. The unanticipated benefits of PrEP for young black gay, bisexual, and other men who have sex with men. AIDS Behav 2019 Nov 25. [Epub ahead of print]
• Koren DE, Scarsi KK, Farmer EK, Cha A, Adams JL, Sheth Pandit N, Chang J, Scott J, et al. A call to action: the role of antiretroviral stewardship in inpatient practice, a joint policy paper of the Infectious Diseases Society of America, HIV Medicine Association, and American Academy of HIV Medicine. Clin Infect Dis 2019 Sep 6. [Epub ahead of print]
• Zuckerman A, Douglas A, Whelchel K, Choi L, DeClercq J, Chastain D. Pharmacologic management of HCV treatment in patients with HCV monoinfection vs. HIV/HCV coinfection: does coinfection really matter? PLoS One 2019;14:e0225434.
• Koren D, Zuckerman A, Teply R, et al. Expanding hepatitis C virus dare and cure: national experience using a clinical pharmacist-driven model. Open Forum Infect Dis 2019;6:ofz316.
• Banks A, Peter M, Holder G, Jolly J, Markley B, Zuckerman S, Choi L, Nwosu S, Zuckerman A. Adherence to disease-modifying therapies at a multiple sclerosis clinic: the role of the specialty pharmacist. J Pharm Pract 2019 Jan 30. [Epub ahead of print]
• Paolella D, Cherry E, Jolly J, DeClercq J, Choi L, Zuckerman A. Closing the gap: identifying rates and reasons for nonadherence in a specialty population. J Manag Care Spec Pharm 2019;25:1182-8.
• Reynolds V, Chinn M, Jolly J, Kelley T, Peter M, Choi L, Nwosu S, Carranza Leon B, Zuckerman A. Integrated specialty pharmacy yields high PCSK9 inhibitor access and initiation rates. J Clin Lipidol 2019;13:254-64.
• Shah N, Haydek J, Slaughter C, Ashton J, Zuckerman A, et al. Risk factors for medication non-adherence to self-injectable biologic therapy in adult patients with inflammatory bowel disease. Inflamm Bowel Dis 2020;26:314-20.
• Shah NB, Jolly JA, Horst SN, Peter M, Limper H, Zuckerman AD. Development of a quality measures tool for the use of self-injectable biologic therapy in inflammatory bowel disease: an integrated specialty pharmacy initiative. Am J Health Syst Pharm 2019;76:1296-304.
• Shah NB, Mitchell RE, Proctor ST, Choi L, DeClercq J, Jolly JA, Hemnes AR, Zuckerman AD. High rates of medication adherence in patients with pulmonary arterial hypertension: an integrated specialty pharmacy approach. PLoS One 2019;14:e0217798.

Other Notable Achievements

• Thomas Chiampas: Elected President-Elect of the Northern Illinois Society of Health-System Pharmacists.
• Monica Mahoney: Presented a CE at ASHP Midyear Meeting 2019 in Las Vegas, Nevada: “Now We Got Bad Blood: Treatment of Bloodstream Infections” (session 239-L01), which was selected as a “Power Hour” presentation.
• Sarah Michienzi:
  Presented a CE at the Illinois Pharmacists Association Annual Meeting 2019 in Springfield, Illinois: “HIV PrEP: A Therapeutics Update and Look at Pharmacists Roles.”
  Interviewed for a February 2020 article in Pharmacy Practice News: “In Prison and Out, Untreated HCV Still Poses Burden.”
• Milena Murray: BCIDP.

Promotions

• Karen Khalil: Clinical Pharmacotherapy Specialist, Abdominal Transplant Service; NYU Langone Health, New York, New York.

Awards

• Lyndsey Bowman: Pharmacist of the Year Award, Tampa General Hospital.

Publications

• Alvey NR, Bowman L, Campara M, Cochrane AB, Cross RP, Crowther B, Doligalski C, Harris MT, Jandovitz N, Kaiser TE, Kane C, Khalil K, Kutzler HL, Laub MR, Maldonado AQ, McCann A, Melaragno JI, Mikolay J Jr, Morris HA, Moss Chandran M, Nelson J, Park JM, Pilch NA, Potter L, Ravichandran BR, Rendulic TA, Schmiedeskamp-Rahe M, Schnelle K, Snyder HS, Sparkes T, Tan T, Trofe-Clark J, Truax C, Valdepenas BT III. (PRN member contributors to the C4 Article). C4 article: Challenges and solutions to appropriate and timely medication access in transplantation in the United States. Am J Transplant 2020;20:362-76.
• Chandran MM. Management of the organ donor. In: Buck ML, Lee BR, eds. Pediatric Self-Assessment Program (PedSAP) 2019, Book 2. Transplantation. Lenexa, KS: American College of Clinical Pharmacy, 2019:145-9.
• Bock M, Wall L, Randall C, Chandran M, et al. Management of dyslipidemia in pediatric renal transplant recipients. Pediatr Nephrol 2020 Jan 2. [Epub ahead of print]
• Cohen E, Formica, R, Batra RK. Side effect–driven conversion to belatacept for kidney transplant recipients in a clinical setting. J Clin Exp Immunol 2020;5:20.
• Nussbaum EZ, Azar MM, Cohen E, et al. Orally administered human immunoglobulin therapy for norovirus enteritis in solid organ transplant recipients: a case series at a single academic transplant center. Clin Infect Dis 2020 Jan 30. [Epub ahead of print]
• Bixby AL, Fitzgerald L, Leek R, Mellinger J, Sharma P, Tischer S. Impact of direct-acting antivirals for hepatitis C virus therapy on tacrolimus dosing in liver transplant recipients. Transpl Infect Dis 2019;21:e13078.

Invited Presentations

• Lyndsey Bowman:
  ACCP IMTR PRN focus session: Asymptomatic bacteriuria in solid organ transplant recipients. ACCP Annual Meeting; October 26-29, 2019; New York, NY.
  Something old, something new, something borrowed, something you: immunomodulating agents for the modern era. Presented at: International Transplant Nurses Society Annual Meeting; November 15-18, 2019; Orlando, FL.
• Tracey Meyers: American Nephrology Nurses Association Renal Update 2020; February 27-28, 2020; Lynnwood, WA.
• Mary Moss Chandran: Conversion to improve adherence: change in formulation or agent immunosuppression in 2019 and beyond: considerations for CNI conversion. American Transplant Congress; June 1-5, 2019; Boston, MA.
• Lisa Potter: Clinical pharmacy specialties: organ transplantation. Plenary lecture presented at: Annual Symposium organized by the National Hospital Pharmacists Association of Romania (ANFSR); December 2019; Cluj-Napoca, Romania.

Posters

• Cohen E, McKimmy D, Kulkarni S. Improving immunosuppression drug accuracy through pharmacy-directed medication reconciliation. European Society of Transplant Congress; 2019.
• Moss Chandran M, Steinberg E, Sikora A, McKinnon K, Bisek M, Goebel J, Bock M. Implementation of a longitudinal comprehensive multidisciplinary transition program and seminar – safely making the long leap to the adult world. American Transplant Congress; June 1-5, 2019; Boston, MA; and Congress of the International Pediatric Transplant Association (IPTA); May 4-7, 2019; Vancouver, British Columbia, Canada.
• Tischer S, Pacurar L, Kumar S, Montgomery J, Wait S. Evaluating opioid restrictive pain management after laparoscopic kidney donation. Am J Transplant 2020;20(S2):20. Platform Presentation at: ASTS Winter Symposium.

Platforms

• Mary Moss Chandran: Impact of once-daily tacrolimus on trough concentration variability in stable adolescent and young adult renal transplant recipients. American Transplant Congress; June 1-5, 2019; Boston, MA; and Congress of the International Pediatric Transplant Association (IPTA); May 4-7, 2019; Vancouver, British Columbia, Canada.

New ACCP Fellows

• Ahmed H. Aljedai
• Barrett R. Crowther
• James N. Fleming
• Angela Q. Maldonado

Introduction

The ID PRN continues to build on its previous successes. Members continue to excel, including publishing over 56 articles and earning 21 new BCIDP certifications! Look for future recertification opportunities with the brand new IDSAP home study materials. Below is a sampling of professional achievements by ID PRN members.

Promotions

• Christina Andrzejewski: Clinical Intelligence Specialist, ID Connect, Inc. (Pittsburgh, PA).
• Rebecca Castner: Associate Professor of Clinical Sciences, Clinical and Administrative Sciences, College of Pharmacy, Roosevelt University (Chicago, IL
• Debra Goff: Professor of Pharmacy, Pharmacy Practice and Science, College of Pharmacy, The Ohio State University (Columbus, OH).
• Krutika Mediwala: Residency Program Director – Infectious Diseases PGY2; Affiliate Assistant Professor – Division of Infectious Diseases, Medical University of South Carolina Health University Medical Center (Charleston, SC).
• Andrea Pallotta: Pharmacy Clinical Coordinator of Infectious Diseases, Cleveland Clinic (Cleveland, OH).

Board Certification in Infectious Diseases (BCIDP)

• Christina Andrzejewski
• Aiman Bandali
• Wiyanna Bruck
• Philip Chung
• Elizabeth Covington
• Chris Destache
• Danielle Dufresne
• Jena Foreman
• Angie Fouts
• Brian Hughes
• Evan Mallory
• Milena Murray
• Mandana Naderi
• Cynthia Nguyen
• Rebecca Nolen
• Kelsey Olson
• Pratish Patel
• Lara Ramey
• Diandra Ruidera
• Bhavik Shah
• Gregory Tallman

Awards

• Jacinda Abdul-Mutakabbir: ECCMID 30 Under 30 Outstanding Young Scientists.
• Sara Alosaimy: First Place Winner: Annual Eugene Applebaum College of Pharmacy and Health Sciences Research Day Outstanding Research Award.
• Amanda Barner: 2019 CHA Medical Staff Rising Star Award.
• Timothy Gauthier: SIDP Gita Patel Best Practice Award.
• Debra Goff: Pharmacy Times Lifetime Achievement Finalist.
• Alan Gross: SHEA Top Oral Research Abstract, IDWeek 2019.
• Betsy Hirsch: Professor of the Year, Twin Cities UMN students, Class of 2020.
• Wesley Kufel: 2019 New York State American College of Clinical Pharmacy Educator of the Year.
• Taylor Morrisette: ACCP Resident/Fellow Travel Award; IDWeek Trainee Travel Grant.
• Milena Murray: Shining Star Award, Illinois Council of Health-System Pharmacists.
• Diandra Ruidera: Preceptor of the Year – California Northstate University School of Pharmacy.
• Michael Rybak: ACCP Infectious Diseases PRN Distinguished Investigator Award.
• Kayla Stover: School of Pharmacy Service Award.

Grants

• Debra Goff: A pharmacist-led prospective study to improve duration of antimicrobial therapy in culture negative sepsis in neonatal intensive care units (NICU) in public and private hospitals across South Africa.
• Betsy Hirsch: Co-Investigator on $160,000 grant funded by University of Minnesota Medical School Academic Investment Clinical Program: “Program to Improve Quality and Safety of Outpatient Parenteral Antibiotic Treatment (OPAT) at UMMC.”
• Justin Moore: 2019 BPS Seed Grant (with co-investigator Sheila Wang).
• Michael Rybak: PI-Initiated Industry grants, NIH R01 subcontract.

Publications

• Abdul-Mutakabbir JC, Kebriaei R, Jorgensen SCJ, Rybak MJ. Teaching an old class new tricks: a novel semi-synthetic aminoglycoside, plazomicin. Infect Dis Ther 2019;8:155-70.
• Almangour TA, Perry GK, Alhifany AA. Dalbavancin versus standard of care for the treatment of osteomyelitis in adults: a retrospective matched cohort study. Saudi Pharm J 2020 Feb 17. [Epub ahead of print]
• Alhifany AA, Almutairi AR, Almangour TA, et al. Comparing the efficacy and safety of faecal microbiota transplantation with bezlotoxumab in reducing the risk of recurrent Clostridium difficile infections: a systematic review and Bayesian network meta-analysis of randomised controlled trials. BMJ Open 2019;9:e031145.
• Alosaimy S, Abdul-Mutakabbir JC, Jorgensen SCJ, Kebriaei R, Rybak MJ. Evaluation of eravacycline: a novel fluorocycline. Pharmacotherapy 2020;40:221-38.
• Alosaimy S, Jorgensen SCJ, Lagnf AM, Melvin S, Mynatt RP, Carlson TJ, Garey KW, Allen D, Venugopalan V, Veve M, Athans V, Saw S, Yost CN, Davis SL, Rybak MJ. Real-world multicenter analysis of clinical outcomes and safety of meropenem-vaborbactam in patients treated for serious gram-negative infections. Open Forum Infect Dis 2020;7:ofaa051.
• Helmi M, Alosaimy S, Goodson JM, et al. Annual alveolar bone loss in older adults taking oral bisphosphonate: a case-control study. BMC Oral Health 2019;19:260.
• Nimarko K, Bandali A, Bias TE, et al. Impact of an antimicrobial stewardship team on reducing antiretroviral medication errors. Ann Pharmacother 2020 Jan 24. [Epub ahead of print]
• Barner A, Bruno-Murtha L. Antimicrobial stewardship centers of excellence: plea for equal opportunity. Clin Infect Dis 2019 Sep 23. [Epub ahead of print]
• Barber KE, Wagner JL, Miller JM, Lewis EA, Stover KR. Impact of obesity in patients with Candida bloodstream infections: a retrospective cohort study. Infect Dis Ther 2020;9:175-83.
• Beccari MV, Seabury RW, Mogle BT, Kufel WD, et al. Cost comparison of AUC:MIC versus trough-based vancomycin monitoring for MRSA bacteremia. J Am Pharm Assoc. 2020 Mar 4. [Epub ahead of print]
• Jorgensen SCJ, Murray KP, Lagnf AM, Melvin S, Bhatia S, Shamim MD, Smith JR, Brade KD, Simon SP, Nagel J, Williams KS, Ortwine JK, Veve MP, Truong J, Huang DB, Davis SL, Rybak MJ. A multicenter evaluation of vancomycin-associated acute kidney injury in hospitalized patients with acute bacterial skin and skin structure infections. Infect Dis Ther 2020;9:89-106.
• Britt RS, LaSalvia MT, Padival S, Patel P, McCoy C, Mahoney MV. Evaluation of inpatient antimicrobial regimens for readmitted outpatient parenteral antimicrobial therapy (OPAT) patients receiving daptomycin or ertapenem for ease of administration. Open Forum Infect Dis 2019;6:ofz496.
• Mootz ML, Britt RS, Mootz AA, Lee GC, Reveles KR, Evoy KE, Chengwen T, Frei CR. Comparative-effectiveness of ceftaroline and daptomycin as first-line MRSA therapy for patients with sepsis admitted to hospitals in the United States Veterans Health Care System. Hosp Pract (1995). 2019;47:186-91.
• Chahine EB, Durham SH, Mediwala KN, Chastain DB, Gauthier TP, Hill BK, Jones BM, Kisgen JJ, Marx A, Stover KR, Worley MV, Bland CM, Bookstaver PB. A baker’s dozen of top antimicrobial stewardship intervention publications in 2018. Open Forum Infect Dis 2019;6:ofz450.
• Chastain DB, Veve MP, Wagner JL. Abnormal QTc syndrome in HIV-infected patients: a systematic review of prevalence and risk factors. Antivir Ther 2019;24:459-65.
• Cho JC, Crotty MP, Kufel WD, Chahine EB, Sofjan AK, Gallagher JC, et al. Learning experiences within infectious diseases pharmacy residency programs in the United States: a cross-sectional survey. Open Forum Infect Dis 2019;6:ofz387.
• Ashraf MS, Gaur S, Bushen OY, Chopra T, Chung P, et al. Diagnosis, treatment, and prevention of urinary tract infections in post-acute and long-term care settings: a consensus statement from AMDA’s Infection Advisory Subcommittee. J Am Med Dir Assoc 2020;21:12-24.e2.
• Anthone J, Boldt D, Alexander B, Carroll C, Ased S, Schmidt D, Vivekanandan R, Destache CJ. Implementation of a health-system wide antimicrobial stewardship program in Omaha, NE. Pharmacy (Basel) 2019;7: pii: E156.
• Goff DA, Kullar R. Can the perfect handshake hold the key to success and sustainability of antimicrobial stewardship programs? Clin Infect Dis 2019 Oct 4. [Epub ahead of print]
• Goff DA, Mangino JE, Glassman AH, et al. Review of guidelines for dental antibiotic prophylaxis for prevention of endocarditis and prosthetic joint infections and need for dental stewardship. Clin Infect Dis 2019 Nov 15. [Epub ahead of print]
• Hemenway AN, Kandil M, MacDowell M. The association of medication knowledge and adherence scores with hospital readmission. Hosp Pharm 2019 Oct 25. [Epub ahead of print]
• Bomkamp JP, Sulaiman R, Hartwell JL, Desai A, Winn VC, Wrin J, Kussin ML, Hiles JJ. Evaluation of a rapid fungal detection panel for identification of candidemia at an academic medical center. J Clin Microbiol 2020;58:pii: e01408-19.
• Berti AD, Hirsch EB. Tolerance to antibiotics affects response. Science 2020;367:141-2.
• Jeffres MN, Kufel WD, Biehle LR, Cho JC, Narayanan N, Gruenberg K, Garcia J, MacDougall C. A comprehensive survey of infectious diseases curriculum among US pharmacy schools. Am J Pharm Educ 2019;83:7168.
• Justo JA, Kufel WD, Avery LM, Bookstaver PB. Penicillin allergy skin testing in the inpatient setting. Pharmacy (Basel) 2019;7:120.
• Kufel WD, Justo JA, Bookstaver PB, Avery LM. Penicillin allergy assessment and skin testing in the outpatient setting. Pharmacy (Basel) 2019;7:pii: E136.
• Kufel WD, Mastro KA, Mogle BT, et al. Providers’ knowledge and perceptions regarding antibiotic stewardship and antibiotic prescribing in rural primary care clinics. J Am Coll Clin Pharm 2020;1-8.
• Mahoney MV, Padival S. Receipt of supratherapeutic dalbavancin. Am J Health Syst Pharm 2020;77:326-8.
• Mallory EK, Beatty NL. Once-daily 2-drug versus 3-drug antiretroviral therapy for HIV infection in treatment-naive adults: less is best? J Clin Outcomes Manag 2019;26:105-8.
• McCreary EK, Kullar R, Geriak M, Zasowski EJ, Rizvi K, Schulz LT, Ouellette K, Vasina L, Haddad F, Rybak MJ, Zervos MJ, Sakoulas G, Rose WE. Multicenter cohort of patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteremia receiving daptomycin plus ceftaroline compared to other MRSA treatments. Open Forum Infect Dis 2019;7:ofz538.
• Michienzi SM, Ladak AF, Pérez SE, Chastain DB. Antiretroviral stewardship: a review of published outcomes with recommendations for program implementation. J Int Assoc Provid AIDS Care 2020;19:2325958219898457.
• Morrisette T, Canada RB, Padgett D, et al. Factors associated with increased hospital length of stain peritoneal dialysis patients with peritonitis: a need for antimicrobial stewardship? Hosp Pharm 2020;55:50-7.
• Morrisette T, Kebriaei R, Lev KL, Morales S, Rybak MJ. Bacteriophage therapeutics: a primer for clinicians on phage-antibiotic combinations. Pharmacotherapy 2020;40:153-68.
• Morrisette T, Van Matre AG, Miller MA, Mueller SW, Bajrovic B, Kaiser J, Barber GR, Fish DN, et al. Oral vancomycin prophylaxis as secondary prevention against Clostridioides difficile infection in the hematopoietic stem cell transplantation and hematologic malignancy population. Biol Blood Marrow Transplant 2019;25:2091-7.
• Patanwala AE, Radosevich JJ, Meshay I, Naderi M, Culver MA, Lee YG, Weinberg JA, Khobrani M, Nix DE. Cefazolin monotherapy versus Cefazolin plus aminoglycosides for antimicrobial prophylaxis of type III open fractures. Am J Ther 2019 Nov 25. [Epub ahead of print]
• Nguyen CT, Davis KA, Nisly S, et al. Treatment of Helicobacter pylori in special patient populations. Pharmacotherapy 2019;39:1012-22.
• Nguyen CT, Huang AM, Nagel JL. Improving antibiotic use through antimicrobial stewardship interventions upon discharge. Infect Control Hosp Epidemiol 2019;40:1327.
• O’Donnell JN, Rhodes NJ, Biehle LR, Esterly JS, Patel TS, McLaughlin MM, Hirsch EB. Assessment of mortality stratified by meropenem minimum inhibitory concentration in patients with Enterobacteriaceae bacteraemia: a patient-level analysis of published data. Int J Antimicrob Agents 2020;55:105849.
• Pallotta AM, Pirzada SA, Shrestha RK, et al. Presentation to HIV care and antiretroviral therapy initiation and response in clinical practice from 2003 through 2013. Int J STD AIDS 2019;30:853-60.
• Pineda EMZ, Spinner ML, Pallotta A, et al. Infectious diseases pre-transplant evaluation improves vaccination rates for liver transplant candidates. Transpl Infect Dis 2019;21:e13160.
• Walker RE, Bass S, Srinivas P, Miranda C, Johnson L, Pallotta AM. Evaluation of three months of once-weekly rifapentine and isoniazid for latent tuberculosis infection. Ann Pharmacother 2019 Nov 15. [Epub ahead of print]
• Pillinger KE, Bouchard J, Withers ST, Mediwala K, McGee EU, Gibson GM, Bland CM, Bookstaver PB. Inpatient antibiotic stewardship interventions in the adult oncology and hematopoietic stem cell transplant population: a review of the literature. Ann Pharmacother 2019 Nov 26. [Epub ahead of print]
• Rhodes NJ, Lopez J, Pham CK, Brake H, Fotis M, Harpe SE, Avedissian S, Scheetz MH. Implementation of an extended-infusion piperacillin-tazobactam dosing protocol: unexpected findings when monitoring safety and compliance with smart pump technology. Pharmacy (Basel) 2019;7:pii: E169.
• Santarossa M, Kilber EN, Wenzler E, et al. BundlED up: a narrative review of antimicrobial stewardship initiatives and bundles in the emergency department. Pharmacy (Basel) 2019;7:pii: E145.
• Albarillo FS, Joyce CJ, Santarossa M. The use of survey-driven feedback to improve antimicrobial stewardship efforts at a single center. Infect Control Hosp Epidemiol 2020;4:252-3.
• Stover KR, Morrison A, Collier T, Schneider L, Wagner JL, Capino AC, Barber KE. Epidemiology and risk factors for bacteremia in pediatric patients. J Pharm Pract 2019 Aug 26. [Epub ahead of print]
• Craddock K, Molino ST, Stranges PM, Suda KJ, Bleasdale SC, Radosta J, Hickner J, Kannampallil T, Shapiro NL, Gross AE. The impact of educational interventions on antibiotic prescribing for acute upper respiratory tract infections in the ambulatory care setting: a quasi-experimental study. J Am Coll Clin Pharm 2020 Jan 17. [Epub ahead of print]
• Ray MJ, Tallman GB, Bearden DT, et al. Antibiotic prescribing without documented indication in ambulatory care clinics: national cross-sectional study. BMJ 2019;367:l6461.
• Trinh TD, Jorgensen SCJ, Zasowski EJ, Claeys KC, Lagnf AM, Estrada SJ, Delaportes DJ, Huang V, Klinker KP, Kaye KS, Davis SL, Rybak MJ. A multicenter study of the real-world use of ceftaroline versus vancomycin for acute bacterial skin and skin structure infections. Antimicrob Agents Chemother 2019;63:pii: e01007-19.
• Trinh TD, Smith JR, Rybak MJ. Parenteral fosfomycin: a new ally in the fight against multidrug-resistant bacterial pathogens. Pharmacotherapy 2019;39:1077-94.
• Jorgensen SCJ, Trinh TD, Zasowski EJ, Lagnf AM, Bhatia S, Melvin SM, Simon SP, Rosenberg JR, Steed ME, Estrada SJ, Morrisette T, Davis SL, Rybak MJ. Evaluation of the INCREMENT-CPE, Pitt Bacteremia and qPitt Scores in patients with carbapenem-resistant Enterobacteriaceae infections treated with ceftazidime-avibactam. Infect Dis Ther 2020 Feb 22. [Epub ahead of print]
• Jorgensen SCJ, Trinh TD, Zasowski EJ, Lagnf AM, Bhatia S, Melvin SM, Steed ME, Simon SP, Estrada SJ, Morrisette T, Claeys KC, Rosenberg JR, Davis SL, Rybak MJ. Real-world experience with ceftazidime-avibactam for multidrug-resistant gram-negative bacterial infections. Open Forum Infect Dis 2019;6: ofz522.
• Jorgensen SCJ, Trinh TD, Zasowski EJ, Lagnf A, Simon S, Bhatia S, Melvin SM, Steed ME, Finch N, Morrisette T, Estrada SJ, Rosenberg JR, Davis S, Rybak MJ. Real-world experience with ceftolozane-tazobactam for multidrug-resistant gram-negative bacterial infections. Antimicrob Agents Chemother 2020 Jan 13. [Epub ahead of print]
• Wenzler E, Santarossa M, Meyer KA, et al. In vitro pharmacodynamic analyses help guide the treatment of complex multidrug-resistant Enterococcus faecium and Enterobacter cloacae bacteremia in a liver transplant patient. Open Forum Infect Dis 2020;7:ofz545.
• Ortwine JK, Zasowski EJ, Pogue JM, Hanni C, Giuliano C, Casapao AM, Mynatt R, Rybak MJ. Relationship status between vancomycin loading dose and treatment failure in patients with MRSA bacteremia: it’s complicated. Infect Dis Ther 2019;8:627-40.
• Ray KM, Zembles TN, Mitchell ML. Urine trouble: optimizing the management of pediatric UTIs in the outpatient setting. J Pharm Soc Wis 2019;22:16-9.

Other Notable Achievements

• Abdul-Mutakabbir JC, Kebriaei R, Stamper K, Maassen P, Lev K, Rybak MJ. Dalbavancin, vancomycin, and daptomycin alone and in combination with cefazolin against resistant phenotypes of Staphylococcus aureus. Presented at: IDWeek 2019 Scientific Poster Session; October 2019; Washington, DC.
• Abdul-Mutakabbir JC, Yim J, Nguyen L, Kebriaei R, Stamper K, Maassen P, Seyesenhamend J, Smith JR, Barber K, Singh N, Raut A, Kaye K, Rybak MJ. The evaluation of the utility in using different synergy testing methods to predict the activity of antibiotic combinations against Acinetobacter baumannii. Presented at: ASHP Midyear Clinical Meeting, Scientific Poster Session; December 2019; Las Vegas, NV.
• Abdul-Mutakabbir JC, Yim J, Nguyen L, Kebriaei R, Stamper K, Maassen P, Seyesenhamend J, Smith JR, Barber K, Singh N, Raut A, Kaye K, Rybak MJ. In vitro synergy of colistin in combination with meropenem or tigecycline against multi-drug resistant Acinetobacter baumannii. Presented at: IDWeek 2019 Scientific Poster Session; October 2019; Washington, DC.
• Sara Alosaimy: Completed SIDP Antimicrobial Stewardship Certificate program.
• Rachel Britt:
  Abstract selected for poster and platform presentation at the Texas Medical Center Antimicrobial Resistance and Stewardship Conference.
  Invited to lecture for the UTMB School of Medicine Master of Physician Assistant Studies and Doctor of Medicine curriculum.
  Invited to speak about stewardship and asymptomatic bacteriuria at the UTMB Geriatric Medicine Conference.
  Wrote an “In the Literature” article for ContagionLive.
• Wiyanna Bruck: Presented an oral abstract at the 4th Annual Middle Tennessee Antimicrobial Stewardship Symposium.
• Stephen Chromi: NVSHP Board of Directors – Director of Public Relations.
• Philip Chung: Achieved AAHIVP certification.
• Alice Hemenway: Graduated with Master of Public Health degree from University of Illinois at Chicago.
• Betsy Hirsch: Invited Panel Member of the Infectious Diseases Society of America 2019 Update of the Urinary Tract Infection Guidelines.
• Monica Mahoney: ASHP Midyear Clinical Meeting presenter of “Now We Got Bad Blood: Treatment of Bloodstream Infections.” (Selected as a “Power Hour” presentation); BCIDP Role-Delineation Panel; NYCSHP webinar: Welcome to the Jungle: Update on New GNR Drugs.
• Krutika Mediwala: BCIDP Item Writer; BCIDP Role-Delineation Panel.
• Michael Rybak: Appointed to ASHP Foundation Research Advisory Council 2019.

Promotions

• Linda Awdishu: Professor, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego.
• Bruce A. Mueller: Senior Associate Dean, University of Michigan College of Pharmacy.

Grants

• Linda Awdishu (Co-Investigator): “Renal Effects of Hormones/Biomarkers in Transgender PrEP Patients.”
• Erin F. Barreto:
  Program Director/Principal Investigator: “Beta-Lactam Individualization for Critically Ill Patients.” Funded by National Institute of Allergy and Infectious Diseases. (K23 AI 143882) December 2019 – November 2024.
  Co-Investigator: “Use of Nephrotoxic Drugs in AKI Survivors at Transitions of Care: Risk for Chronic Kidney Disease.” Funded by American Society of Health-System Pharmacists. March 2019 – September 2020.
  AKI Survivorship Pilot – A Multiprofessional Approach to Care Transitions. Funded by Midwest Clinical Practice Committee Innovation Award. January 2020 – December 2020.
• Wendy St. Peter (Co-Investigator). United States Renal Data System Coordinating Center Contract: HSN 75N94019C00006.

Publications

• Awdishu L, Moore T, Morrison M, et al . A primer on quality assurance and performance improvement for multidisciplinary chronic kidney disease care: a path to Joint Commission certification. Pharmacy (Basel) 2019;7:pii: E83.
• Awdishu L, Singh RF, Saunders I, et al. Advancing pharmacist collaborative care within academic health systems. Pharmacy (Basel) 2019;7:pii: E142.
• Barreto EF, Nemecek BD. Renal disease and renal replacement therapy overview. In: Nemecek BD, Hammond DA, eds. Demystifying Drug Dosing in Renal Dysfunction. Bethesda, MD: American Society of Health-System Pharmacists, 2019:1-14.
• Barreto JN, Piche SL, Hogan BM, Barreto EF. Effect of a multimodal multidisciplinary training program on pharmacy residents’ knowledge and confidence toward research and biostatistics. Curr Pharm Teach Learn 2020;12:20-6.
• Kurani S, Hickson LJ, Thorsteinsdottir B, Barreto EF, et al. Supplement use by US adults with CKD: a population-based study. Am J Kidney Dis 2019;74:862-5.
• Kurani S, Jeffery MM, Thorsteinsdottir B, Hickson LJ, Barreto EF, et al. Use of potentially nephrotoxic medications by U.S. adults with chronic kidney disease: NHANES, 2011-2016. J Gen Intern Med 2019 Dec 2. [Epub ahead of print]
• Lam SW, Barreto EF, Scott R, et al. Cost-effectiveness of second-line vasopressors for the treatment of septic shock. J Crit Care 2020;55:48-55.
• Rizvi MS, Nei AM, Gajic O, Barreto EF. The authors reply. Crit Care Med 2020;48:e79-e80.
• Zhao Y, Seelhammer TG, Barreto EF, et al. Altered pharmacokinetics and dosing of liposomal amphotericin B and isavuconazole during extracorporeal membrane oxygenation. Pharmacotherapy 2020;40:89-95.
• Nguyen T, Ren S, Hussaine J, et al. Role of potassium-sparing diuretics in the management of hypokalemia in peritoneal dialysis. Am J Ther 2019 Sep 24.
• Nguyen T, Ro E, Tso C. A review on secondary hyperparathyroidism in patients with chronic kidney disease. NJ J Pharm 2019;93:4-7.
• Nguyen T, Wong E, Ciummo C. Polypharmacy in older adults: practical applications alongside a patient case. J Nurse Pract 2020;16:205-9.
• Nguyen T, Wong E, Wang Z, et al. SOAP notes during APPEs: assessment of student performance. J Pharm Pract 2019 Nov 6. [Epub ahead of print]
• Hampson K, Nguyen T. A review of intravenous iron replacement medications for nurse practitioners. J Nurse Pract 2020;16:224-7.
• Wong E, Nguyen T. Evaluating the safe use of antidepressants in older adults: a case-based approach. Sr Care Pharm 2020;35:29-33.
• Flythe JE, Hilliard T, Lumby E, Castillo G, Orazi J, Abdel-Rahman, Pai AB, Rivara MB, St. Peter WL, et al.; for the Kidney-Health Initiative Prioritizing Symptoms of ESRD Patients for Developing Therapeutic Interventions Stakeholder Meeting Participants. Fostering innovation in symptom management among hemodialysis patients: paths forward for insomnia, muscle cramps, and fatigue. Clin J Am Soc Nephrol 2019;14:150-60.
• Rojanasarot S, Nevold JH, Karaca-Mandic P, St. Peter WL, et al. Enhancing guideline-based asthma care processes through a multi-state, multi-center quality improvement program. J Asthma 2019;56:440-50.
• Wigneswaran J, St. Peter WL, Nissenson AR, et al. Redefining medication management in dialysis: a kidney pharmacy quality pyramid. Kidney Med 2019;1:307-14.

Other Notable Achievements

• Linda Awdishu:
  Editorial Board for Kidney360, Journal of the American Society of Nephrology.
  Member of the American Board of Internal Medicine, Nephrology Board.

Awards

• Jason Karnes: 2019 ACCP New Investigator Award.

Grants

• Jason Karnes: Flinn Foundation (PIs: Karnes, Heise). 11/1/18 – 10/31/20. Seed Grant to Promote Translational Research in Precision Medicine. “Large-Scale Implementation of Pharmacogenomics: Translating Genotype-Guided Warfarin Dosing from Discovery to the Bedside.”

Publications

• Arwood MJ, Vahabi N, Lteif C, et al. Transcriptome-wide analysis associates ID2 expression with combined pre- and post-capillary pulmonary hypertension. Sci Rep 2019;9:19572.
• Lteif C, Arwood MJ, Kansal M, et al. Beta-blocker dose stratifies mortality risk in a racially diverse heart failure population. J Cardiovasc Pharmacol 2020;75:250-8.
• Weitzel KW, Duong BQ, Arwood MJ, Owusu-Obeng A, et al. A stepwise approach to implementing pharmacogenetic testing in the primary care setting. Pharmacogenomics 2019;20:1103-12.
• Cicali EJ, Smith DM, Duong BQ, Kovar LG, Cavallari LH, et al. A scoping review of the evidence behind cytochrome P450 2D6 isoenzyme inhibitor classifications. Clin Pharmacol Ther 2020 Jan 7. [Epub ahead of print]
• Relling MV, Klein TE, Gammal RS, Whirl-Carrillo M, Hoffman JM, Caudle KE. The Clinical Pharmacogenetics Implementation Consortium: 10 years later. Clin Pharmacol Ther 2020;107:171-5.
• Hasan MJ, Rabbani R, Bachar SC. Therapeutic specification of the last resort polymyxins: an intelligent approach. Int J Infect 2019;6:e96828.
• Hicks JK, Bishop JR, Gammal RS, Sangkuhl K, Bousman C, Leeder JS, Llerena A, Mueller DJ, Ramsey LB, Scott SA, Skaar TC, Caudle KE, et al. A call for clear and consistent communications regarding the role of pharmacogenetics in antidepressant pharmacotherapy. Clin Pharmacol Ther 2020;107:50-2.
• Karnes J (listed 310 of 333 authors); All of Us Research Program Investigators. The “All of Us” research program. N Engl J Med 2019;381:668-76.
• Karnes JH, Wiener HW, Schwantes-An T, et al. Genetic admixture and survival in diverse populations with pulmonary arterial hypertension. Am J Respir Crit Care Med 2020 Jan 9. [Epub ahead of print]
• Ilori T, Viera E, Wilson J, Moreno F, Menon U, Ehiri J, Peterson R, Vemulapalli T, StimsonRiahi S, Rosales C, Calhoun E, Sokan A, Karnes J, et al. Approach to high volume enrollment in clinical research: experiences from an All of Us research program site. Clin Transl Sci 2020 Jan 31. [Epub ahead of print]
• Luzum JA, Ting C, Peterson EL, et al. Association of regulatory genetic variants for protein kinase Cα with mortality and drug efficacy in patients with heart failure. Cardiovasc Drugs Ther 2019;33:693-700.
• Smith DM, Peshkin BN, Springfield TB, et al. Pharmacogenetics in practice: estimating the clinical actionability of pharmacogenetic testing in perioperative and ambulatory settings. Clin Transl Sci 2020 Jan 21. [Epub ahead of print]
• Mehta D, Uber R, Ingle T, et al. Study of pharmacogenomic information in FDA-approved drug labeling to facilitate application of precision medicine. Drug Discov Today 2020 Feb 4. [Epub ahead of print]

Other Notable Achievements

• Meghan Arwood:
  Current landscape of precision medicine clinics: approaches from various practitioners to improve the fit of those genes! Accepted: session proposal for ASCPT Annual Meeting; March 21, 2020; Houston, TX.
  Appointed Vice Chair of the American Society for Clinical Pharmacology and Therapeutics (ASCPT) Pharmacogenomics Community (March 2020 – March 2021).
• Md Jahidul Hasan: Joined Long Island University as a Preceptor.

Grants

• Jennifer Austin Szwak: University of Chicago Medicine, “Outpatient Principles in Addiction Training and Education (OPIATE) Initiative,” Association of American Medical Colleges Curricular Innovation Award, $2500, Team Member.

Publications

• Lee C, Austin Szwak J, Bastow S, et al. Impact of a nurse-driven diabetic ketoacidosis insulin infusion calculator on the rate of hypoglycemia. J Patient Saf 2019 Nov 19. [Epub ahead of print]
• Boylan PM, Santibañez M. Case report of upper gastrointestinal bleeding in a male patient taking rivaroxaban and megestrol acetate. Sr Care Pharm 2019;34:501-9.
• Boylan PM, Sedlacek J, Santibañez M, et al. Development and implementation of interprofessional relations between a college of pharmacy and osteopathic residency programs in a community teaching hospital. J Pharm Technol 2020;36:3-9.
• Gershman J. What pharmacists need to know about COPD and transitions of care. Drug Topics 2019;6:24-5.
• Malesker MA, Callahan-Lyon P, Madison JM, et al.; CHEST Expert Cough Panel. Chronic cough due to stable chronic bronchitis: CHEST Expert Panel Report. Chest 2020 Feb 24. [Epub ahead of print]
• Santibañez M, Bunnell K, Harrington A, et al. Association between pharmacokinetic/pharmacodynamic derived predictions of efficacy and clinical outcomes in obese and non-obese patients with Enterobacteriaceae bloodstream infections. Open Forum Infect Dis 2019;6:ofz400.
• Daniels C, Santibañez M. Diversity considerations in selecting a residency program. In: Caballero J, Benavides S, Clauson KA, eds. Get the Residency: ASHP’s Guide to Residency Interviews and Preparation, 2nd ed. Bethesda, MD: American Society of Health-System Pharmacists, 2019:85-96.
• Dingman JS, Smith ZR, Coba VE, et al. Argatroban dosing requirements in extracorporeal life support and other critically ill populations. Thromb Res 2020;189:69-76.
• Martirosov AL, Smith ZR, Hencken L, et al. Improving transitions of care for critically ill adult patients on pulmonary arterial hypertension medications. Am J Health Syst Pharm. [In press]
• Stuart M, Smith ZR, Payter K, et al. Pharmacist-driven discontinuation of antipsychotics started for ICU delirium: a quasi-experimental study. J Am Coll Clin Pharm 2020. [In press]

Awards

• Lori Wilken: Jesse Stewart Service Award, University of Illinois at Chicago College of Pharmacy.

Promotions

• Rebecca M. Castner: Associate Professor of Clinical Sciences, Roosevelt University College of Pharmacy.
• Audra Wilson: Clinical Pharmacy Specialist (Tele-Women’s Health), VISN 20 Clinical Resource Hub, Boise VA Medical Center.

Awards

• Shareen El-Ibiary and Erin Raney together with a team: Award of Excellence in Experiential Education from the American Association of Colleges of Pharmacy.
• Lauren Lakdawala: Distinguished Young Pharmacist Award 2019, Maryland Pharmacist Association.

Publications

• Arellano R, Ball J, Mospan C, Patel J. Hormonal contraception: from emergency coverage to long-term therapy. In: Covvey JR, Arya V, DiPietro Mager N, et al., eds. Public Health in Pharmacy Practice: A Casebook, 1st ed. Genesco, NY: Open SUNY Textbooks, 2020.
• Leader LD, O’Connell M, VandenBerg A. Brexanolone for postpartum depression: clinical evidence and practical considerations. Pharmacotherapy 2019;39:1105-12.
• Stone RH, Hur S, Young HN. Assessment of naloxone stock status in Georgia retail pharmacies. J Am Pharm Assoc (2003). 2019 Dec 19. [Epub ahead of print]
• Stone RH, Rafie S, Shealy K, Griffin B, et al. Pharmacist self-perception of readiness to prescribe hormonal contraception and additional training needs. Curr Pharm Teach Learn 2020;12:27-34.
• Ti A, Stone RH, Whiteman M, et al. Safety and effectiveness of hormonal contraception for women who use opioids: a systematic review. Contraception 2019;100:480-3.

New ACCP Fellows

• Lamis R. Karaoui
• Sally Rafie

Other Notable Achievements

• Bartelme K, LaDisa A: Conversations with health professions educators about their innovative teaching strategies: an interview with Dr. LaDisa and Dr. Bartelme! “Take two pills … and listen to this podcast.”
• Alicia B. Forinash: Selected to serve on an NIH task force on research specific to pregnant and lactating women.